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Friedreich’s ataxia (FRDA) is caused by the transcriptional silencing of the frataxin
(FXN) gene. FRDA patients have expansion of GAA repeats in intron 1 of the FXN gene
in both alleles. A number of studies demonstrated that specific histone deacetylase
inhibitors (HDACi) affect either histone modifications at the FXN gene or FXN
expression in FRDA cells, indicating that the hyperexpanded GAA repeat may facilitate
heterochromatin formation. However, the correlation between chromatin structure and
transcription at the FXN gene is currently limited due to a lack of more detailed analysis.
Therefore, I analyzed the effects of the hyperexpanded GAA repeats on transcription
status and chromatin structure using lymphoid cell lines derived from FRDA patients.
Using chromatin immunoprecipitation and quantitative PCR, I observed significant
changes in the landscape of histone modifications in the vicinity of the GAA tract in
FRDA cells relative to control cells. Similar epigenetic changes were observed in GFP
reporter construct containing 560 GAA repeats. Further, I detected similar levels of FXN
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pre-mRNA at a region upstream of hyperexpanded GAA repeats in FRDA and control
cells, indicating similar efficiency of transcription initiation in FRDA cells. I also
showed that histone modifications associated with hyperexpanded GAA repeats are
independent of transcription progression using the GFP reporter system. My data strongly
support evidence that FXN deficiency in FRDA patients is consequence of defective
transition from initiation to elongation of FXN transcription due to heterochromatin-like
structures formed in the proximity of the hyperexpanded GAAs.
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Chapter 1. Introduction and Background

Some parts of this dissertation were modified from the following journal article.
Eunah Kim, Marek Napierala, Sharon Y.R. Dent. Hyperexpansion of GAA repeats
affects post-initiation steps of FXN transcription in Friedreich’s ataxia, Nucleic Acids
Research, (2011) 39(19): 8366-8377.
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1. FRDA
Clinical and pathological aspects
Friedreich’s ataxia (FRDA) is an degenerative neuro-muscular disease that affects 1 in
50,000 individuals in the United States (Delatycki, Williamson and Forrest, 2000). The
features of FRDA are recessively inherited with an incidence of one in 60 to 100
depending on the ethnic group (Cossee, Schmitt, Campuzano, Reutenauer, Moutou,
Mandel and Koenig, 1997). FRDA is characterized by progressive ataxia, including
uncoordinated gait and limb movements, weakened muscle strength, and diminished
senses of position and vibration. FRDA involves degeneration of the posterior columns of
the spinal cord that is extended to the brain stem. FRDA patients also exhibit atrophy in
the spinocerebellar tract, a set of axonal fibers in the spinal cord terminating in the
cerebellum. In the dorsal root ganglion within the spinal cord, large primary sensory
neurons are also degenerated in FRDA patients. Quantitative analysis reveals that contact
between Purkinje cells in the cerebellum and dendrites are decreased, while the cerebellar
cortex is not affected in patients of FRDA. These phenomena indicate that FRDA patients
are most likely defective in providing information from the spinal cord through the
spinocerebellar tract, which lead loss of position and vibration sense. Additionally,
hypertropic cardiomyocytes are observed in approximately 80% of FRDA patients
(Campuzano, Montermini, Lutz, Cova, Hindelang, Jiralerspong, Trottier, Kish, Faucheux,
Trouillas, Authier, Durr, Mandel, Vescovi, Pandolfo and Koenig, 1997). Such
cardiomyocytes contain abnormal intracellular iron deposits, suggesting that this feature
of FRDA is associated with defective function of iron metabolism.
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The role of FXN in mitochondria
The FRDA disease gene is genetically mapped to chromosome 9q13 and encodes the
Frataxin protein (FXN), a nuclear encoded mitochondrial protein (Campuzano,
Montermini, Lutz, Cova, Hindelang, Jiralerspong, Trottier, Kish, Faucheux, Trouillas,
Authier, Durr, Mandel, Vescovi, Pandolfo and Koenig, 1997; Campuzano, Montermini,
Molto, Pianese, Cossee, Cavalcanti, Monros, Rodius, Duclos, Monticelli, Zara,
Canizares, Koutnikova, Bidichandani, Gellera, Brice, Trouillas, De Michele, Filla, De
Frutos, Palau, Patel, Di Donato, Mandel, Cocozza, Koenig and Pandolfo, 1996). FRDA is
characterized by insufficient levels of FXN mRNA and protein in all examined tissues
(Campuzano, Montermini, Lutz, Cova, Hindelang, Jiralerspong, Trottier, Kish, Faucheux,
Trouillas, Authier, Durr, Mandel, Vescovi, Pandolfo and Koenig, 1997). Most functions
of FXN have been demonstrated from yeast since yeast is viable without the yeast FXN
homolog, Yfh1p, while FXN is an essential protein in mouse (Adinolfi, Iannuzzi, Prischi,
Pastore, Iametti, Martin, Bonomi and Pastore, 2009; Bulteau, O'Neill, Kennedy, IkedaSaito, Isaya and Szweda, 2004; Cossee, Puccio, Gansmuller, Koutnikova, Dierich,
LeMeur, Fischbeck, Dolle and Koenig, 2000). Yfh1p plays a role in the storage of iron
within mitochondria (Babcock, de Silva, Oaks, Davis-Kaplan, Jiralerspong, Montermini,
Pandolfo and Kaplan, 1997). During iron homeostasis, FXN acts as a chaperone (Bulteau,
O'Neill, Kennedy, Ikeda-Saito, Isaya and Szweda, 2004). Negatively charged FXN binds
ferrous iron to balanced levels of iron (Dhe-Paganon, Shigeta, Chi, Ristow and Shoelson,
2000). FXN has a ferroxidase activity when the concentration of ferrous iron is low in
mitochondria leading to iron detoxification. Insufficient levels of FXN expression result
in abnormal biosynthetic processes through a defective utilization of iron such as
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decreased activities of iron-sulfur cluster (ISC) enzymes, accumulation of iron in
mitochondria, and increased susceptibility to oxidative stress (Wilson, 2003). Oxidative
stress is caused by oxygen excess in mitochondria due to an impaired ability to maintain
homeostasis by detoxifying oxidative molecules. Decreased activity of ISC is associated
with a dysfunction of respiratory chain leading to exacerbation of oxidative stress
conditions (Jensen, Sanchez, Srinivasan, Valentine and Culotta, 2004). Oxidative stress
observed in FRDA patient possibly results from FXN deficiency through impaired ISC in
mitochondria. However, the underlying mechanisms of FRDA have not yet been fully
elucidated. FXN is evolutionarily conserved from yeast to humans, in particular in the Cterminal region. Interestingly, an exogeneous protein consisting of the C-terminus of
human FXN fused to the N-terminus of Yfh1p complements the phenotype of Yfh1p
deficient yeast (Wilson and Roof, 1997). Yfh1p precursor is processed to a 122-amino
acid protein through cleavage by the mitochondrial processing protease (MPP) (Gordon,
Shi, Dancis and Pain, 1999). Human FXN is similarly processed to a 128-amino acid
protein from a 210-amino acid precursor. A N-terminal portion of FXN contains a
mitochondrial signal sequence that is removed by the MPP. Unlike Yfh1p, FXN is
processed through two-step cleavages (Schmucker, Argentini, Carelle-Calmels, Martelli
and Puccio, 2008). The first cleavage occurs between Gly41 and Leu42 by MPP,
generating a 169-amino acid intermediate protein in mitochondria. The second cleavage
between Lys80 and Ser81 brings into being the 130-amino acid mature form of FXN.
Only the final mature 130-amino acid form is functional in mitochondria. Ectopic
expression of the mature form of FXN efficiently rescues the lethality of FXN null
fibroblasts (Schmucker, Argentini, Carelle-Calmels, Martelli and Puccio, 2008).
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Consistently, residues 90-210 of FXN have been demonstrated to be rigid by
crystallography and NMR structure (Dhe-Paganon, Shigeta, Chi, Ristow and Shoelson,
2000; Musco, Stier, Kolmerer, Adinolfi, Martin, Frenkiel, Gibson and Pastore, 2000).
This suggests that C-terminal region of FXN is functional as mentioned above while Nterminal region is responsible for localization of FXN into mitochondria. Indeed, residues
90-210 correspond to an α1-helix and β1-sheet of the core structure of FXN that has
potential to either function to donate iron to its partner or to form multimers (DhePaganon, Shigeta, Chi, Ristow and Shoelson, 2000). Although the processed forms of
FXN are associated with FRDA pathology, it is noteworthy that defects in the process of
FXN maturation are not. This emphasizes that enhancement of FXN transcription will be
critical for curing FRDA.

Differential expression of the FXN gene
Since there is no evidence that FXN RNA is abnormally processed to make mature FXN
RNA in FRDA, insufficient levels of FXN in FRDA likely result from the stage of FXN
transcription. The FXN gene consists of 7 exons (Figure 1). The major transcripts contain
exon 1 to 5a and are pronounced in all examined tissues of the patients (Kostrzewa,
Klockgether, Damian and Muller, 1997). Other isoforms are occasionally detected in the
heart. The FXN gene is differentially expressed in various tissues. The human FXN gene
is mainly expressed in primary sites of degeneration in FRDA patients such as liver, heart
and CNS, particularly in the spinal cord (Campuzano, Montermini, Molto, Pianese,
Cossee, Cavalcanti, Monros, Rodius, Duclos, Monticelli, Zara, Canizares, Koutnikova,
Bidichandani, Gellera, Brice, Trouillas, De Michele, Filla, De Frutos, Palau, Patel, Di
Donato, Mandel, Cocozza, Koenig and Pandolfo, 1996).
5

Figure 1. Schematic diagram of the human FXN gene.
Black bars represent exons (exon1, 2, 3, 4, 5a, and exon 5b). Light gray bar represents
non-coding exon that is involved in regulating the expression of the gene and does not
lead to additions to the protein sequence. Exons 5a and 5b are alternatives and result in
slightly different protein sequences. Exon1~5a produce major FXN transcripts. The FXN
gene is displayed in correct proportion.
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Figure 1
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The mouse FXN gene is differentially expressed during development. Expression is
gradually increased from embryonic day 10 (E10) to later stages, appearing the highest at
E14. In the spinal cord, a characteristic pattern of FXN expression becomes evident at
E12.5, particularly in the thoracolumbar region that is most likely composed of large
neuronal cells in the DRG (Jiralerspong, Liu, Montermini, Stifani and Pandolfo, 1997). In
the adult brain, expression is restricted to the ependymal layer, chorid plexus, and
granular layer of the cerebellum. This pattern indicates that FXN expression in various
tissues is correlated with FRDA pathology, suggesting that changes in FXN transcription
is likely responsible for FRDA.

Mutation at the FXN gene in FRDA patients (Expansion of GAA repeats at
the FXN gene in FRDA)
Approximately 98% of FRDA patients are characterized by abnormal GAA repeat
expansions within intron 1 of the FXN gene in both alleles (Figure 2), while 2% of FRDA
patients have either point mutations or missense mutations in the FXN gene that act as
null mutations (Bidichandani, Ashizawa and Patel, 1998; Campuzano, Montermini,
Molto, Pianese, Cossee, Cavalcanti, Monros, Rodius, Duclos, Monticelli, Zara,
Canizares, Koutnikova, Bidichandani, Gellera, Brice, Trouillas, De Michele, Filla, De
Frutos, Palau, Patel, Di Donato, Mandel, Cocozza, Koenig and Pandolfo, 1996; Ohshima,
Sakamoto, Labuda, Poirier, Moseley, Montermini, Ranum, Wells and Pandolfo, 1999).
The GAA repeat at the FXN gene is detected in the middle of an Alu repeat element. In
addition, a polymorphic mononucleotide tract of adenines (poly A tract) was identified in
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Figure 2. Mutation of the FXN gene in FRDA patients.
Expansion of GAA repeats is located within intron 1 of the FXN gene in FRDA patients.
Black bars represent exon 1 and 2, while light gray bar represents non-coding exon 6.
More than 1,700 GAA repeats are observed in FRDA patient, whereas less than 66 GAA
repeats is detected in unaffected individuals. The region between exon 1 and exon 2 is
displayed in correct proportion.
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Figure 2
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the vicinity of the GAA triplet repeat (Monticelli, Giacchetti, De Biase, Pianese, Turano,
Pandolfo and Cocozza, 2004). Reduced levels of the FXN
gene expression in FRDA patients are correlated with the hyperexpanded tract of
repeated GAA triplets (Campuzano, Montermini, Molto, Pianese, Cossee, Cavalcanti,
Monros, Rodius, Duclos, Monticelli, Zara, Canizares, Koutnikova, Bidichandani, Gellera,
Brice, Trouillas, De Michele, Filla, De Frutos, Palau, Patel, Di Donato, Mandel, Cocozza,
Koenig and Pandolfo, 1996; Grabczyk and Usdin, 2000a). In FRDA patients, the GAA
tract frequently consists of more than 1500 triplets, whereas unaffected individuals have
66 or fewer repeats at the FXN gene (Campuzano, Montermini, Molto, Pianese, Cossee,
Cavalcanti, Monros, Rodius, Duclos, Monticelli, Zara, Canizares, Koutnikova,
Bidichandani, Gellera, Brice, Trouillas, De Michele, Filla, De Frutos, Palau, Patel, Di
Donato, Mandel, Cocozza, Koenig and Pandolfo, 1996; Pandolfo, 1998; Pianese, Turano,
Lo Casale, De Biase, Giacchetti, Monticelli, Criscuolo, Filla and Cocozza, 2004). About
85% of unaffected individuals have fewer than 12 GAA repeats whereas the remainder
has 12 to 33 repeats.

Expansion of the GAA triplet
Expansion or contraction in size of the GAA repeat tracts is commonly observed during
intergenerational transmission from parents to children. Although the underlying
mechanism for how the size of the repeats is expanded has not yet been demonstrated, it
has been suggested that DNA metabolism such as repair, replication, and recombination
is involved in the flexibility of the GAA triplet size among generations. The mismatch
repair (MMR) pathway is involved in inheritance and stability of the pathological repeats
among generations (Krasilnikova, Kireeva, Petrovic, Knijnikova, Kashlev and Mirkin,
11

2007; Mirkin, 2007). In longer GAA repeats, single-stranded DNA is exposed to form
hairpin DNA structures. MMR machinery is recruited to the hairpin structure, which
leads to repeat expansion (Krasilnikova, Kireeva, Petrovic, Knijnikova, Kashlev and
Mirkin, 2007). During DNA replication, exposed single stranded DNA containing GAA
repeats enables folding into secondary DNA structures, which cause expansion of GAA
repeats through misalignment of repetitive DNA (Ohshima and Wells, 1997).
Recombination pathways also contribute to expansion of the GAA repeats. Longer GAA
repeats are associated with a high frequency of recombination in E.coli, which results in
expansion of the GAA repeats (Napierala, Dere, Vetcher and Wells, 2004). However, the
detailed mechanisms are not clear.

The effect of the GAA repeats on gene expression
Previous studies demonstrate that the long GAA tracts cause transcriptional pausing in in
vitro as well as in cell culture systems (Grabczyk and Usdin, 2000b; Krasilnikova,
Kireeva, Petrovic, Knijnikova, Kashlev and Mirkin, 2007). Oligonucleotides containing
longer GAA repeats show abnormal migration mobility on agarose gels when compared
to linear DNA consisting of random sequences (Ohshima, Montermini, Wells and
Pandolfo, 1998). Abnormal DNA structures of constructs containing longer GAA repeats
have been observed by nuclear magnetic resonance (LeProust, Pearson, Sinden and Gao,
2000). Polypurine/polypyrimidine DNA sequences containing mirror repeat symmetry
form distinctive non-canonical structures. Either a pyrimidine or a purine rich singlestranded DNA is intertwined into the major groove of a double helix consisting of the
hyperexpanded GAA repeats forming intermolecular interactions between the strands in
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in vitro systems (Sakamoto, Chastain, Parniewski, Ohshima, Pandolfo, Griffith and
Wells, 1999). Integration of oligodeoxyribonucleotides into longer GAA repeats block
formation of the non-canonical DNA structure leading to restoration of full-length FXN
transcripts in a concentration-dependent manner (Grabczyk and Usdin, 2000a). Small
molecules recognizing specific DNA sequences such as polyamides de-repress FXN
expression in cellular systems (Dervan and Edelson, 2003; Gottesfeld, 2007; Gottesfeld,
Turner and Dervan, 2000). T7 RNA polymerase is impeded in the vicinity of GAA
repeats in in vitro systems(Grabczyk and Usdin, 2000b). These results explain the
correlation between size of the GAA repeats and defective transcription in FRDA.

Treatments of FRDA
Although the mechanism of how hyperexpanded GAA repeats down-regulate FXN
expression in FRDA patient remains unclear, a number of studies have been carried out
to identify compounds that enhance the expression of FXN in FRDA. To date, several
compounds have been reported to increase FXN expression in cellular models, including
hemin, butyric acid (Sarsero, Li, Wardan, Sitte, Williamson and Ioannou, 2003), and
erythropoietin (Sturm, Stupphann, Kaun, Boesch, Schranzhofer, Wojta, Goldenberg and
Scheiber-Mojdehkar, 2005) by unknown mechanisms.

As FXN deficiency in FRDA results in increasing free radicals accompanied by abnormal
accumulation of iron in mitochondria, both antioxidants and iron chelators have been
applied to patients as a therapy to alleviate symptoms of FRDA. To date, only idebenone,
a synthetic analogue of coenzyme Q10, has been demonstrated in a phase III trial as free
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radical chelator (a treatment pipeline in the Friedreich's Ataxia Research Alliance
(www.fara.org)). Unfortunately, a recent study has reported that idebenone does not
improve neurological symptoms of FRDA in pediatric patients (Lynch, Perlman and
Meier, 2010).

Although the treatments mentioned above have improved the progress of FRDA, there
are no effective treatments for curing FRDA. Enhancement of FXN expression from
FXN cDNA harboring viral vectors partially alleviates FXN deficiency and defective
response to oxidative stress (Fleming, Spinoulas, Zheng, Cunningham, Ginn, McQuilty,
Rowe and Alexander, 2005; Gomez-Sebastian, Gimenez-Cassina, Diaz-Nido, Lim and
Wade-Martins, 2007; Lim, Palomo, Mauritz, Gimenez-Cassina, Illana, Wandosell and
Diaz-Nido, 2007). These studies suggest that restoring FXN levels is likely to be more
effective for FRDA treatment than targeting downstream consequences of FXN
deficiency. These studies make the point that understanding the underlying mechanisms
of how FXN expression is affected by hyperexpanded tracts of GAA repeats in patients
with FRDA is critical to developing therapeutic targets for curing FRDA.

Models for study of FRDA
As previously mentioned, an effective treatment has not yet developed for curing FRDA.
Nevertheless, various systems have been applied to investigate the molecular pathology
of FRDA. Each system has different purpose for study.

•

Escherichia coli (E.coli)
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E.Coli has been used to investigate the propensity of longer GAA repeats to form non BDNA structures that are associated with abnormal replication and defective transcription
in a length-dependent manner (Grabczyk and Usdin, 2000b). Moreover, persistent
RNA_DNA hybrids in the presence of longer GAA repeats was first identified in E.coli
(Grabczyk, Mancuso and Sammarco, 2007). RNA transcribed from long GAA repeats is
hybridized with exposed single-stranded DNA to form persistent RNA_DNA hybrids,
which inhibit transcription. Therefore, E.coli has been useful to define how non-B DNA
structures consisting of longer GAA repeats act as cis-inhibitors of DNA metabolism.

•

Yeast

Yeast is an appropriate model system to investigate the function of FXN since YFH1
deficient yeast survive (Wilson and Roof, 1997). Moreover, similar to human and mouse
FXN, yeast FXN homologue contains a potential mitochondrial targeting sequence in the
N-terminus of YFH1. Therefore, deletion of YFH1 in yeast strain provided evidence to
demonstrate that FXN acts as an iron chaperone in mitochondria (Babcock, de Silva,
Oaks, Davis-Kaplan, Jiralerspong, Montermini, Pandolfo and Kaplan, 1997).

•

Mouse models

Mouse models for FRDA have been generated to study the mechanism of the pathology
and to test pharmacological therapies.
o FXN null/conditional KO/inducible KO
FXN null mice that have constitutive inactivation of FXN by homologous recombination
are embryonic lethal, indicating that FXN is essential for development (Cossee, Puccio,
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Gansmuller, Koutnikova, Dierich, LeMeur, Fischbeck, Dolle and Koenig, 2000).
However, these mice did not exhibit defective iron metabolism during development,
suggesting that lethality of the null embryos is independent of the iron metabolism
defects caused. To further understand the lethality caused by knockout (KO) of FXN,
conditional KO mice were generated using Cre-lox system specific to skeletal and cardiac
muscle (Puccio, Simon, Cossee, Criqui-Filipe, Tiziano, Melki, Hindelang, Matyas, Rustin
and Koenig, 2001). The conditional FXN KO mice were viable and resembled the
phenotype of FRDA patients such as large sensory neuron dysfunction and deficient
activity of mitochondria. Although this model did not exhibit susceptibility to oxidative
stress, this phenomenon is also controversial in FRDA patients. This result suggests that
the susceptibility to oxidative stress is not a major consequence of FXN deficiency.
Therefore, these mice models that have insufficient levels of FXN without GAA repeats
are appropriate to investigate the role of FXN and the pathological process of FRDA
independent of the GAA repeats.
o GAA in mice
In an effort to define the effects of the GAA repeats in the pathology of FRDA, a
transgenic mouse model (knock in-knock in (KIKI) mice) that contains a tract of GAA
repeats was generated by insertion of 230 GAA into the first intron of the mouse Fxn
gene and then mated with Fxn -/- mice (Miranda, Santos, Ohshima, Smith, Li, Bunting,
Cossee, Koenig, Sequeiros, Kaplan and Pandolfo, 2002). The offspring (Fxn 230/-) have
25~36% reduction of FXN expression relative to wild type. Unfortunately, these mice did
not phenocopy a FRDA in despite of reduced levels of Fxn caused by the insertion of the
GAA repeats. This finding suggests that 230 GAA repeats are insufficient to stimulate
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pathology of FRDA. Moreover, this study also suggests that the appropriate location of
the GAA repeat at a given gene might be a major factor in exhibition of FRDA
pathology, as the location of the repeat in the mouse Fxn gene is not comparable to the
location of the GAA repeats in human FXN gene. Nevertheless, this is a first FRDA
mouse model to exhibit FXN deficiency caused by the presence of the GAA repeat.
o YAC-GAA in mice
To overcome embryonic lethality of FXN KO model, transgenic mice were generated by
introducing 190 or 190/90 GAA repeats in intron 1 of the human FXN gene within a
human YAC clone in the background of FXN null mice (Al-Mahdawi, Pinto, Ruddle,
Carroll, Webster and Pook, 2004; Pook, Al-Mahdawi, Carroll, Cossee, Puccio, Lawrence,
Clark, Lowrie, Bradley, Cooper, Koenig and Chamberlain, 2001). These transgenic mice
exhibited typical FRDA phenotypes such as coordination deficits and a progressive
decrease in motor activity in younger mice (3 month old), indicating that location of the
GAA repeat is considerable when compared to KIKI mice. Histological studies in this
model showed similarities to FRDA patients such as large vacuoles in dorsal root ganglia
cells and iron deposits in cardiomyocytes, whereas electrophysiological studies showed a
mild, progressive peripheral neuropathy (Al-Mahdawi, Pinto, Varshney, Lawrence,
Lowrie, Hughes, Webster, Blake, Cooper, King and Pook, 2006). Moreover, this model
showed tissue-specific and age-dependent somatic instability specifically in the
cerebellum and dorsal root ganglia (Clark, De Biase, Malykhina, Al-Mahdawi, Pook and
Bidichandani, 2007). Especially, a HDACi enhances FXN expression accompanying with
increased levels of acetylation on histones in the KIKI mice. This outcome is meaningful
that removal of marks associated heterochromatin-like structures has potential to alleviate
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FXN deficiency in FRDA. However, it is unclear that the observed phenomenon resulted
from the GAA repeats rather than from the construct per se.

•

Lymphoid cell lines

Patient-derived lymphoid cell lines immortalized by Epstein-Barr virus available in the
Coriell Institute (http://www.coriell.org). Moreover, cells from unaffected control
individuals that contain a range of the GAA repeats are available for comparison studies.
Therefore, the lymphoid cell lines are perhaps the best system to address my hypothesis
since the presence of expanded GAA repeats at the FXN locus does not result in
degeneration of these lymphoid cell lines.

•

The GFP_GAA system

To avoid effects from inherent characteristics of the FXN gene so that changes induced
by the hyperexpanded GAA repeats per se can be determined, the GAA repeat derived
from a FRDA patient (the GM16210 cell line from Coriell Institute) was engineered into
an intronic region originating from the human Pem1 gene that is known to be spliced
efficiently during RNA processing (Figure 3). The Pem intronic region containing the
GAA repeat is embedded into the middle of the GFP coding region to divide the GFP
coding region. The CMV promoter controls expression of this construct to avoid inherent
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Figure 3. The GFP_GAA system.
Schematic diagram of the GFP gene containing GAA repeats in the GFP_(GAATTC)
reporter system. The GFP gene was divided into two exons (gray boxes) by the intron
containing 560 GAA repeats. This reporter system is expressed under control of the CMV
promoter (black box) and the tetracycline operator/repressor (TetO)2 (white boxes) that
allows regulating transcription initiation by tetracycline. BGH pA represent bovine
growth hormone and polyadenylation signal that is used during mRNA processing.
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characteristics of the FXN promoter. A tetracycline operator element was also inserted in
the promoter region so that GFP expression is regulated by tetracycline treatment,
reducing the possibility of genomic instability associated with transcription of repetitive
DNA sequences. This reporter construct genetically recapitulates the location of the GAA
repeats as characteristics of the endogenous FXN gene. Moreover, the GFP_GAA system
is validated as a model system to investigate molecular pathway associated with FXN
expression changes (Soragni, Herman, Dent, Gottesfeld, Wells and Napierala, 2008). The
insertion of the GAA repeats results in reduction of GFP mRNA. The intronic region in
the proximity of the GAA repeat has increased histone modifications marking
heterochromatin and decreased modifications marking euchromatin. Furthermore, small
drugs that affect modifications on chromatin structure restore GFP expression in the
GFP_(GAATTC) 560 cell line.

Section 2 of this chapter will describe general information about epigenetics, which
might play a role in down-regulating FXN transcription through the hyperexpanded GAA
repeats in FRDA.

2. Epigenetics regulation of FXN expression
In eukaryotes, the genome is organized into arrays of nucleosomes composed of histones
and DNA. The histones are classified as H1, H2A, H2B, H3, and H4. Two copies of
H2A, H2B, H3, and H4 compose a core octamer around which is wrapped around 146
base pair (bp) DNA to form a nucleosome (Luger, Mader, Richmond, Sargent and
Richmond, 1997). Chromatin is categorized into either euchromatin or heterochromatin,
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depending on the conformation of structure, status of transcription, and post-translation
modifications of histones. Configuration of chromatin structure is less packed in
euchromatin. Moreover, transcription occurs more in euchromatin. In contrast,
heterochromatin is characterized by condensed chromatin structure, rich in repetitive
DNA, which is rarely transcribed in eukaryotes and plants (Grewal and Jia, 2007).
Heterochromatin comprises most portions of both centromeres and telomeres in
mammals. Genes localized in heterochromatin are most likely silenced (Grewal and Jia,
2007). This phenomenon suggests that gene expression is regulated by not only trans
through transcription machinery but also cis through organization of chromatin
structures.

Regulation of Chromatin structures
•

Post-translational modifications of Histones

Regulation of chromatin structure is involved in various cellular functions such as
DNA repair, replication as well as transcription by specific covalent marks in the Nterminal tails of histones such as acetylation (ac) and methylation (me) (Li, Carey and
Workman, 2007). Although a number of lysine residues have been identified as targets
for modifications, this thesis will focus on well characterized sites of acetylation and
methylation of histone H3 and H4 (Figure 4).

Lysine residues in the amino-terminal regions of the histones are acetylated dependent on
the status of transcription and on temporal and spatial conditions such as tissue specificity
and development. Most acetylated histones are readily detected at transcriptionally active
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Figure 4. Diagram of histone modifications at the amino-terminal tails of histone H3
and H4 in each chromatin structure (euchromatin and heterochromatin).
Each chromatin structure has distinct combination of histone modifications as shown in
diagram. DNA wrapped around histone octamer consisting of pairs of H2A, H2B, H3 and
H4. Each histone exhibits a flexible histone tail that can be dynamically modified. Shown
here are histone modifications examined in this study. Blue oval represent a methyl group
on lysine residue. Green oval represent acetyl group on lysine residue.
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genes, particularly, in regulatory regions. Acetylation of lysines in histones neutralize the
positive charge on histones and thereby decrease interactions between histones and
DNAs. Therefore, transcription machinery is better able to access chromatin structures
that are hyper acetylated. In contrast, lack of acetyl group on histone results in
compaction of chromatin structure leading to gene silencing. Inhibition of histone
deacetylation using HDACi is promising to enhance expression of a given gene. Indeed,
many diseases such as neurodegenerative diseases and cancers have been treated with
HDACi to alleviate symptoms through regulation of histone acetylation. In
heterochromatin, acetylation is rarely detected as compared to euchromatin. Moreover,
higher eukaryotic heterochromatin is associated with heterochromatin protein (HP1), first
identified at pericentric heterochromatin in Drosophila. HP1 contributes to formation
and maintenance of heterochromatin by multimerization of HP1 through ‘chromo
domain’ at the N-terminal and ‘chromo shadow domain’ at the C-terminal domain of the
HP1. Gene silencing associated with HP1 is relived by inhibition of histone deacetylase,
TSA, suggesting that hypoacetylation plays a role in HP1 mediated
heterochromatinization. However, HP1 is also observed in euchromatin where genes are
transcribed (Ayyanathan, Lechner, Bell, Maul, Schultz, Yamada, Tanaka, Torigoe and
Rauscher, 2003), suggesting that additional proteins or histone modifications may be
involved to HP1-mediated gene silencing. Acetylation of lysine of proteins can serve as
binding sites for effector molecules that contain ‘bromodomains’. GCN5 is an
acetyltransferase that is found in SAGA (Spt-Ada-Gcn5-acetyltransferase) complex. The
GCN5 bromodomain-mediated interaction with acetylated histones promotes stability of
SAGA complex at target genes, which maintain chromatin structure as euchromatin along
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with increased levels of acetylation on histones. These results suggest a role of
bromodomain as a modulator of chromatin modifying/remodeling complexes (Li and
Shogren-Knaak, 2009).
Methylation of histones is involved in either active or repressive chromatin structures,
depending on either the number of methyl groups present on the targeted residue and
which residue is targeted in the histones (Li, Carey and Workman, 2007). While
acetylation occurs only at lysine residues, either lysine or arginine residues can be
methylated. Methylation at lysine 9 of histone H3 is enriched in heterochromatin, while
acetylation at lysine 9 of histone H3 is enriched in euchromatin, where genes are actively
transcribed. Methylation at lysine 9 of histone H3 prevents acetylation, promoting gene
silencing. Methylation at lysine 9 of histone H3 at heterochromatin provides a binding
site for HP1 protein to stimulate condensing of chromatin structures through the chromo
domain and chromo shadow domain (Jenuwein and Allis, 2001). HP1 at the region where
H3K9me3 are enriched act as anchor to recruit chromatin-remodeling complex to further
modify histones. Although the majority of H3K9me3 is associated with repressed and
silenced regions throughout the genome, this histone modification is also found in the
coding regions of transcriptionally active genes (Vakoc, Mandat, Olenchock and Blobel,
2005). In centromeric heterochromatin, where gene expression is repressed, enrichment
of H4K20me3 is accompanied by enrichment of H3K9me3 (Kourmouli, Jeppesen,
Mahadevhaiah, Burgoyne, Wu, Gilbert, Bongiorni, Prantera, Fanti, Pimpinelli, Shi,
Fundele and Singh, 2004; Schotta, Lachner, Sarma, Ebert, Sengupta, Reuter, Reinberg
and Jenuwein, 2004).
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During development, genes are appropriately either turning on or off at a given stage.
Methylation at lysine 27 of histone H3 is well-characterized and is important in the
regulation of gene expression during development. H3K27me3 is mainly detected in
repressive chromatin structures such as the inactive X chromosome as well as in
inducible genes that are required for a given stage of development. In embryonic stem
cells, H3K4me3 is co-localized with H3K27me3 at the promoter of some genes, called
bivalent genes. The silenced gene expression at the bivalent gene is reversed by the
removal of H3K27me3, and then H3K4me3 becomes pronounced for these genes as cells
differentiate. To switch off gene expression, methylation of H3K4 is removed by a
demethylase such as a lysine-specific demethylase (LSD) 1 leading to over representation
of H3K27me3 at the bivalent gene during differentiation or development (Seenundun,
Rampalli, Liu, Aziz, Palii, Hong, Blais, Brand, Ge and Dilworth, 2010). This
phenomenon is also observed in non-developmental inducible genes such as a heat-shock
gene, Hsp70, in Drosophila (Gilmour and Lis, 1986). RNA polymerase II (RNA pol II)
are accompanying with H3K4me3 at the promoter. Once the repressive mark is removed,
paused RNA pol II is released from the promoter to produce full-length transcripts.
During on going transcription, H3K4me3 is mainly observed at the 5’ end of genes,
representing initiation of transcription (Barski, Cuddapah, Cui, Roh, Schones, Wang,
Wei, Chepelev and Zhao, 2007). The presence of H3K4me3 accompanying with H3S10p
is preventing recruitment of a enzyme that methylases a lysine 9 of histone H3 as a
repressive mark (Dormann, Tseng, Allis, Funabiki and Fischle, 2006). During elongating
transcript, the lysine 36 of histone H3 are methylated by a Set domain containing
methyltransferase that is recruited to an active form of RNA pol II phosphorylated at

27

Figure 5. Distribution of histone modifications across genes to define chromatin
structures.
This pattern is generated by genome scale screening by several groups of histone
modifications in yeast and mammalian cells by ChIP-seq. The middle represents
euchromatin that is enriched in H3K4me2/3 and H3K9ac at TSS of genes during
transcription initiation and H3K79me2 and H3K36me3 in the body of genes during
transcription elongation. Both ends represent heterochromatin that is compacted more
than euchromatin as shown here. As I mentioned before, H3K9me3 and H4K20me3 are
mainly enriched in heterochromatin.
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distributed across genes and are associated with transcriptional status (Figure 5). This
discrete enrichment of each histone modifications at a given gene suggests that
coordination of histone modifications is essential for regulation of gene expression.

•

DNA methylation

DNA methylation is an epigenetic event that is frequently observed in silenced gene
expression. The C-5 position of cytosine is predominantly methylated in CG dinucleotide
rich regions that are mainly located within regulatory regions such as gene promoters.
These CG rich regions are generally unmethylated, but become methylated upon gene
silencing. There are two possibilities to explain how DNA methylation is associated with
gene silencing. First, during transcription, the accessibility of regulatory elements
embedded into DNA sequences to either transcription machinery or transcription factors
is inhibited by DNA methylation. Alternatively, there are proteins that specifically
recognize methylated DNA such as the methyl-CpG-binding domain (MBD) containing
protein, MeCP2. MBD proteins exist in mammals and bind to methylated CG residues in
in vitro (Ng, Zhang, Hendrich, Johnson, Turner, Erdjument-Bromage, Tempst, Reinberg
and Bird, 1999). Secondly, the methylated DNA may influence the configuration of
chromatin structures. Indeed, high levels of DNA methylation affect the preference of
histones to incorporate into certain DNA sequence in in vitro (Davey, Pennings and
Allan, 1997).
Interaction between histone methyltransferase and DNA methyltransferase supports that
DNA methylation is associated with configuration of chromatin structure (Cedar and
Bergman, 2009). In embryonic stem cells, SUV39H1 and SUV39H2 responsible for
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H3K9me3 recruit DNA methyltransferase 3A and 3B to add methyl groups on CpG
residues in satellite repetitive DNA (Lehnertz, Ueda, Derijck, Braunschweig, PerezBurgos, Kubicek, Chen, Li, Jenuwein and Peters, 2003). The methylated CpG is possibly
recognized by MBD proteins, which recruit chromatin modifying/remodeling complexes
leading to further heterochromatinization (Jones, Veenstra, Wade, Vermaak, Kass,
Landsberger, Strouboulis and Wolffe, 1998). However, the relation between chromatin
structures and DNA methylation in gene expression is not yet completely clear.
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Suggested effect of the GAA repeats at the FXN gene leading to FXN
deficiency in FRDA patients.
Among various factors contributing to heterochromatin formation, high density of
repetitive DNA, such as found in transposons, is a main stimulator across the genome
(Grewal and Jia, 2007). Hyperexpanded GAA repeats have been reported to adopt a
heterochromatin-like structure that is characterized by increased levels of di- and
trimethylated lysine 9 of histone H3 (H3K9me2/3) and decreased acetylation on H3 and
H4 at the FXN gene (Al-Mahdawi, Pinto, Ismail, Varshney, Lymperi, Sandi, Trabzuni
and Pook, 2008; Rai, Soragni, Jenssen, Burnett, Herman, Coppola, Geschwind,
Gottesfeld and Pandolfo, 2008; Saveliev, Everett, Sharpe, Webster and Festenstein, 2003;
Soragni, Herman, Dent, Gottesfeld, Wells and Napierala, 2008). Inhibition of histone
deacetylases restores levels of FXN expression in FRDA primary lymphocytes and in a
murine model (Herman, Jenssen, Burnett, Soragni, Perlman and Gottesfeld, 2006; Rai,
Soragni, Jenssen, Burnett, Herman, Coppola, Geschwind, Gottesfeld and Pandolfo, 2008),
and manipulating histone modifications, particularly acetylation, can partially enhance
expression of the FXN gene. Therefore, these studies suggest that changes in chromatin
structure associated with the hyperexpanded GAA repeats induce FXN repression.
However, it is an open question whether the heterochromatin-like structure induced by
the hyperexpanded tract of GAA repeats impacts initiation and/or elongation of FXN
transcription. Some studies show that the heterochromatin-like structure induced by the
hyperexpanded GAA repeats impact promoter activity, which affect initiation of FXN
transcription (De Biase, Chutake, Rindler and Bidichandani, 2009; Kumari, Biacsi and
Usdin). Marks enriched in heterochromatin such as H3K27me3, H3K9me3 and
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heterochromatin protein (HP1) are detected at the transcription start site (TSS) of the
FXN gene in FRDA fibroblast lines, leading to the failure of FXN transcription initiation.
These repressive marks may also influence expression of FXN antisense transcripts in the
proximity of the TSS, thereby interfering with initiation of FXN sense transcripts in
FRDA patients (De Biase, Chutake, Rindler and Bidichandani, 2009). Other studies
suggest that both defective initiation and transcript elongation is affected in FRDA
(Kumari, Biacsi and Usdin, 2011b). Levels of both H3K4me3, indicator of active
transcription initiation at the TSS of the FXN gene and H3K36me3, an indicator of
transcription elongation, are decreased at the FXN gene in FRDA cell lines.

Besides altered histone modifications in the proximity of the hyperexpanded GAA
repeats at the FXN gene in FRDA, high levels of DNA methylation have been reported in
the region upstream of the GAA repeats in FRDA cell lines (Castaldo, Pinelli, Monticelli,
Acquaviva, Giacchetti, Filla, Sacchetti, Keller, Avvedimento, Chiariotti and Cocozza,
2008; Greene, Mahishi, Entezam, Kumari and Usdin, 2007). Moreover, the levels of
DNA methylation correlate with the number of the GAA repeats (Castaldo, Pinelli,
Monticelli, Acquaviva, Giacchetti, Filla, Sacchetti, Keller, Avvedimento, Chiariotti and
Cocozza, 2008). Taken together, these observations suggest that epigenetic alterations
induced by the hyperexpanded GAA repeats are associated with regulation of FXN
expression in FRDA.
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Current knowledge gap in molecular mechanisms to understand FXN
deficiency via the hyperexpanded GAA repeats in FRDA patients.
Epigenetic alterations caused by the hyperexpanded GAA repeats are one of the potential
therapeutic targets for curing FRDA. Mouse models containing a longer GAA repeats
tract exhibit sensitivity to epigenetic modifiers, suggesting that epigenetic regulation by
the GAA repeats is likely a good target for potential drugs in restoring FXN expression
(Festenstein, Sharghi-Namini, Fox, Roderick, Tolaini, Norton, Saveliev, Kioussis and
Singh, 1999; Saveliev, Everett, Sharpe, Webster and Festenstein, 2003). Moreover, a
number of studies showed that specific HDACi are capable of FXN expression and
increasing histone acetylation in FRDA cells (Herman, Jenssen, Burnett, Soragni,
Perlman and Gottesfeld, 2006; Rai, Soragni, Jenssen, Burnett, Herman, Coppola,
Geschwind, Gottesfeld and Pandolfo, 2008; Soragni, Herman, Dent, Gottesfeld, Wells
and Napierala, 2008). In contrast, levels of H3K9me3, a repressive mark, observed in the
proximity of the long GAA repeats are maintained upon HDACi treatment (Herman,
Jenssen, Burnett, Soragni, Perlman and Gottesfeld, 2006; Rai, Soragni, Jenssen, Burnett,
Herman, Coppola, Geschwind, Gottesfeld and Pandolfo, 2008). Moreover, FXN
expression has no association with inhibition of H3K9 methylation using a small
molecule in FRDA cells (Grabczyk and Usdin, 2000a). These results suggest that two or
more epigenetic silencing pathways may be simultaneous involved in regulation of FXN
expression. Additionally, although DNA methylation is one of major factors associated
with gene silencing, investigations of how DNA methylation might be involved in FXN
deficiency have been limited to date. Therefore, this thesis provides a detailed definition
of the spectrum of chromatin structure changes associated with hyperexpanded GAA
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repeats in order to further understand the molecular mechanisms underlying FXN
deficiency in FRDA cells.
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The purpose of this study is to determine whether the hyperexpanded
GAA repeats foster epigenetic changes associated with the formation of
heterochromatin-like structures leading to inhibition of FXN
transcription in FRDA.
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Chapter 2. Materials and Methods

Some parts of this dissertation were modified from the following journal article:
Eunah Kim, Marek Napierala, Sharon Y.R. Dent. Hyperexpansion of GAA repeats
affects post-initiation steps of FXN transcription in Friedreich’s ataxia, Nucleic Acids
Research, (2011) 39(19): 8366-8377.
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Cells
Lymphoid cell lines were purchased from NIGMS Human Genetic Cell Repository at
The Coriell Institute for Medical Research, Camden, NJ, USA. I selected three cell lines
derived from FRDA patients: GM15850 harboring two expanded alleles of approximately
650 and 1030 GAA repeats; GM16798 harboring two expanded alleles of approximately
750 and 1000 GAA repeats and GM16209 harboring approximately 800 GAA repeats on
both alleles of the FXN gene. As controls, I also used three lymphoid cell lines
(GM15851, GM03928 and GM05152) derived from healthy, unaffected individuals
containing short GAA repeat tracts within a normal range. Lymphoid cell lines were
grown in RPMI 1640 medium supplemented with 15% FBS, 100U/ml penicillin and 100
µg/ml streptomycin at 37°C in 5% CO2. The GFP_GAA systems [GFP_(GAATTC)0
and GFP_(GAATTC)560] were generated by integration of a tract of GAA repeats
derived from the GM16210 affected cells as described previously (Soragni, Herman,
Dent, Gottesfeld, Wells and Napierala, 2008). A DNA fragment harboring approximately
560 GAA repeats was PCR amplified from genomic DNA isolated from the GM16210
cell line (NIGMS Human Genetic Cell Repository at The Coriell Institute for Medical
Research, Camden, NJ, USA) as described in (Soragni, Herman, Dent, Gottesfeld, Wells
and Napierala, 2008). PCR product was cleaved by Bsu36I and BssHII endonucleases
and the GAA repeat containing fragment was cloned into intron 1 (1.2Kbp from the
exon1/intron1 junction) of the GFP gene of the pGFP_Int plasmid (Seluanov, Mittelman,
Pereira-Smith, Wilson and Gorbunova, 2004; Wilson and Roof, 1997). Plasmids
containing 0 and 560 GAA repeats were integrated by site-specific recombination into the
genome of the HEK293Flp-InT-Rex cell line (Invitrogen). The use of identical sites of
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integration for both GFP_(GAATTC)0 and GFP_(GAATTC)560 constructs allows
direct comparison between cell lines and eliminates any potential bias resulting from
random integration events in different chromosomal contexts. Integrants were selected
using hygromycin (200 µg/ml); individual hygromycin-resistant colonies were isolated
and analyzed for repeat size and GFP expression level. Correct splicing of the GFP
mRNA was determined as described earlier (Campuzano, Montermini, Molto, Pianese,
Cossee, Cavalcanti, Monros, Rodius, Duclos, Monticelli, Zara, Canizares, Koutnikova,
Bidichandani, Gellera, Brice, Trouillas, De Michele, Filla, De Frutos, Palau, Patel, Di
Donato, Mandel, Cocozza, Koenig and Pandolfo, 1996). All constructs were sequenced
prior to as well as after establishing the stable cell lines. The GFP_GAA lines were
selectively maintained in Dulbecco’s Modified Eagle’s Medium with 10% FBS, 100
U/ml penicillin and 100 µg/ml streptomycin at 37°C in 5% CO2 supplemented with
hygromycin (200 µg/ml) and blasticidin (5 µg/ml). To induce transcription of the GFP
minigene in the GFP_GAA system, cells were treated with 0.1 µg/ml tetracycline for 24h.

Polymerase chain reaction (PCR)
The size of the hyperexpanded tract of GAA repeats in lymphoid cell lines were
determined by conventional PCR using primers 2500F and 629 under previously
described conditions (Campuzano, Montermini, Molto, Pianese, Cossee, Cavalcanti,
Monros, Rodius, Duclos, Monticelli, Zara, Canizares, Koutnikova, Bidichandani, Gellera,
Brice, Trouillas, De Michele, Filla, De Frutos, Palau, Patel, Di Donato, Mandel, Cocozza,
Koenig and Pandolfo, 1996). The insertion of the GAA repeats at an intron of the GFP
gene in the GFP_GAA system was detected by the conventional PCR using the primers
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listed in Table 1. The PCR products were analyzed on 0.8% agarose gels. To perform
quantitative reverse transcriptase PCR (qRT-PCR), total RNAs from lymphoid cell lines
and the GFP_GAA system were isolated using the RNeasy Mini Kit (Qiagen). DNase I
(TURBO DNA-free; Ambion) was added to remove genomic DNA contamination from
isolated RNAs. The qRT-PCR was conducted using the Power SYBR Green RNA-to-CT
1-Step Kit (7500 Fast Real Time-PCR System, Applied Biosystems). As a control,
reactions were also performed without reverse transcriptase to confirm a removal of
genomic DNA. To calculate levels of FXN expression, the delta Ct value was generated
by subtraction of the Ct value of GAPDH from the Ct value of either FXN mRNA or 4
different region transcripts of each cell line. Levels of FXN mRNA from each cell line
were normalized to the delta Ct of GM15851. For levels of FXN pre-mRNA expression,
each delta Ct value of 4 different regions at the FXN gene was normalized to the delta Ct
value of the region upstream of the GAA repeat from GM15851. All primers used in this
study are listed in Tables 1 and 2.

Chromatin immunoprecipitation (ChIP)
ChIP was performed according to the EZ ChIP instructions (Upstate Biotechnology Inc.).
Briefly, proteins and DNA were cross-linked with 1% formaldehyde for 10min (15min in
the case of RNA pol II ChIP) at room temperature. The cross-linking reaction was
quenched with 125mM glycine for 5min (10min in the case of RNA pol II ChIP). Whole
lysates were prepared by using a cell lysis buffer (50mM Tris-HCl at pH8.0, 10mM
EDTA, and 1% SDS) supplemented with protease inhibitor (Mini EDTA-free protease
inhibitor cocktail, Roche) and sonicated to obtain 100 to 300 bp DNA fragments using a
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Bioruptor Sonicator (Diagenode). The fragmented chromatin was diluted 10 times with
dilution buffer (16.7mM Tris-HCl at pH8.0, 167mM NaCl, 1.2mM EDTA, 1.1% Triton
X-100, and 0.01% SDS). The chromatin fragments were pre-cleared for 1h using Protein
A agarose (Millipore) pre-blocked with BSA and salmon sperm DNA. The equivalent of
5 x 106 (1 x 107 cells in the case of RNA pol II ChIP) cells was immunoprecipitated
overnight with 5µg of antibodies recognizing histone modifications (15µg of RNA pol II
antibody in the case of RNA pol II ChIP). For total histone H3 and H4, the equivalent of
5 x 106 cells was immunoprecipitated with 3µg of antibodies recognizing histone H3 and
H4 after estimating saturation point between antibody for antibody and antigen. The
immunoprecipitates were immobilized on the pre-blocked protein A agarose beads for 1h.
Subsequently, the beads were washed with buffers containing low salt, high salt, and
LiCl, chromatin was eluted from the beads with elution buffer (100mM NaHCO3 and 1%
SDS) at room temperature for 15min twice and subsequently subjected to the reverse
cross-linking reaction using 5M NaCl at 65°C for at least 5h. The DNAs from chromatin
complexes were isolated with Tris-EDTA buffer (80mM Tris-HCl at pH6.5, and 20mM
EDTA) supplemented with Protienase K and RNase A at 37°C for 30min followed by
42°C for 1h. DNA fragments were purified using phenol/chloroform extraction before
quantitative real-time PCR (qPCR). The qPCR was conducted using the Power SYBR
Green-CT Kit (7500 Fast Real Time-PCR System, Applied Biosystems). The qPCR was
carried out as follows: 10 min at 94°C, 50 cycles of 30s at 94°C followed by 60s at 60°C.
Since changes in nucleosome occupancy is associated with gene activation and gene
silencing (Bryant, Prabhu, Floer, Wang, Spagna, Schreiber and Ptashne, 2008), it is
worthy to notice that the changes of histone modifications (referred to as the “relative
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fold over total H3”) determined by qPCR was analyzed by normalizing the quantity of
the immunoprecipitated sample to the quantity of total histone H3 (total H4 in the case of
H4K20me3) after normalization to inputs.

Antibodies
The antibodies used in this study were anti-rabbit IgG as a negative control (Cell
Signaling), anti-total H3 (Cell Signaling or Active Motif) and anti-total H4 (Abcam),
anti-H3K9/14ac (Upstate), anti-H3K4me2 (Active Motif), anti-H3K4me3 (Abcam or
Active Motif), anti-H3K9me3 (Upstate or Active Motif), anti-H3K27me3 (Abcam), antiH3K36me3 (Upstate), anti-H3K79me2 (Upstate or Active Motif), anti-H4K20me3
(Active Motif), and an antibody against the large subunit of RNA polymerase II (N20;
Santa Cruz Biotechnology).

D-ribofuranosylbenzimidazole (DRB) treatments
To optimize condition of DRB treatments in the lymphoid cell lines, various
concentration, 1, 50, and 100 µM of DRB was applied to 1 x 106 cells for 5 hr. H3K4me3
distribution was determined using ChIP assay upon inhibition of transcription elongation
by DRB in the lymphoid cell lines as described in the ChIP section of Materials and
Methods.

Statistics
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A 2-way analysis of variance followed by the Bonferroni post-hoc test were performed to
determine the statistical significance of the results of qRT-PCR and ChIP analysis
between unaffected and FRDA cell lines.
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Table 1. Primers used for analyses in the GFP_GAA reporter system.
Primer (5’ to 3’)
Repeat

Forward

CTTCCCTTTACACAACGTTTGGGTT

Reverse

GTACTGTTTGGATTCAGTGAGGGACT

Forward

GCGACGTAAACGGCCACAAGTT

Reverse

ATGCCCTTCAGCTCGATGCGGT

Forward

GACGACGGCAACTACAAGACC

Reverse

CTAGGACAAAGGTGCCTAAGACC

Forward

AATAGCCTCCTGACCACAGATCCTT

Reverse

CCATGTGACATCTAGCCCCGCA

Forward

CCCACAGGCCTGAAACACT

Reverse

TTCATGCGTGCTAGGGTAAA

Forward

CCCTAGCACGCATGAACC

Reverse

ATGCCCTTCAGCTCGATGCGGT*

Ex1/Ex2

Ex1/Int

Up

Down

Int/Ex2

* This primer is the same as the GFP Ex1/Ex2 reverse primer.
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Table 2. Primers used for analyses in the lymphoid cell lines.
Primer (5’ to 3’)
Forward

CCTTGCAGACAAGCCATACA

Reverse

GGTCCACTGGATGGAGAAGA

Forward

AGCACTCGGTTACAGGCACT

Reverse

GCCCAAAGTTCCAGATTTCC

Forward

CGCATTTTATAAACAAGGCACA

Reverse

GTATGTGGGGCCAGGAGAC

Pro

Forward

CCCCACATACCCAACTGCTG

(or -133)

Reverse

GCCCGCCGCTTCTAAAATTC

Forward

AAGCAGGCTCTCCATTTTTG

Reverse

CCGCAGGCACTCTTCTGT

Up

Forward

GAAACCCAAAGAATGGCTGTG

(or +1231)

Reverse

TTCCCTCCTCGTGAAACACC

Forward

GGTACGCCGCATGTATTAGG

Reverse

GCAACCAATCCCAAAGTTTC

Forward

CTGGAAAAATAGGCAAGTGTGG

Reverse

CAGGGGTGGAAGCCCAATAC

Forward

GGTAATCATGTTTTGGGTTTTGTGC

Reverse

AGTCCTCAAACGTGTATGGCTTGTC

Ex3/Ex4

In1Ex2

–242

+48

+1394

Down

In2Ex3

Number on the name of primers denotes the first base of forward primer on the target
region with respect to the TSS, +1.
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Chapter 3. Defining of chromatin structure in the vicinity of
the hyperexpanded GAA repeats at the FXN gene

Some parts of this dissertation were modified from the following journal article:
Eunah Kim, Marek Napierala, Sharon Y.R. Dent. Hyperexpansion of GAA repeats
affects post-initiation steps of FXN transcription in Friedreich’s ataxia, Nucleic Acids
Research, (2011) 39(19): 8366-8377.
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GAA repeat expansion and FXN deficiency in the lymphoid cell lines
In order to discriminate lengths of the GAA repeats at the FXN gene in the lymphoid cell
lines from unaffected (GM15851, GM03928 and GM05152) and FRDA patients
(GM15850, GM16798 and GM16209), conventional PCR was carried out using a primer
set that recognizes sequences surrounding where the GAA repeats at the FXN gene as
previously reported (Campuzano, Montermini, Molto, Pianese, Cossee, Cavalcanti,
Monros, Rodius, Duclos, Monticelli, Zara, Canizares, Koutnikova, Bidichandani, Gellera,
Brice, Trouillas, De Michele, Filla, De Frutos, Palau, Patel, Di Donato, Mandel, Cocozza,
Koenig and Pandolfo, 1996). A band around 500 bp is detected in unaffected controls,
whereas FRDA lymphoid cell lines exhibit expanded GAA repeats up to 3Kbp (Figure 6).
This pattern is consistent with number of the GAA repeats reported in NIGMS Human
Genetic Cell Repository at The Coriell Institute for Medical Research as described in
Materials and Methods.

To confirm insufficient levels of FXN transcription in FRDA cell lines, FXN mature RNA
was masured by qRT–PCR using a primer set recognizing exon 3 as a forward primer and
exon 4 as a reverse primer (Figure 7). Clinically affected FRDA patients express as little
as 5% and as much as 35% of FXN relative to unaffected individuals (Campuzano,
Montermini, Molto, Pianese, Cossee, Cavalcanti, Monros, Rodius, Duclos, Monticelli,
Zara, Canizares, Koutnikova, Bidichandani, Gellera, Brice, Trouillas, De Michele, Filla,
De Frutos, Palau, Patel, Di Donato, Mandel, Cocozza, Koenig and Pandolfo, 1996;
Pianese, Turano, Lo Casale, De Biase, Giacchetti, Monticelli, Criscuolo, Filla and
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Cocozza, 2004). In order to establish a common epigenetic profile in FRDA cell lines, I
selected three cell lines expressing low (GM16798), medium (GM15850), and high
(GM16209) levels of the FXN mRNA corresponding to 8, 17 and 29% of the FXN
mRNA found in the GM15851, respectively.
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Figure 6. Hyperexpanded GAA repeats at the FXN gene in the lymphoid cell lines.
Hyperexpanded tract of GAA repeats (indicated by the asterisk) was confirmed by
conventional PCR in lymphoid cell lines derived from patients with FRDA but not in cell
lines derived from unaffected individuals.
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Figure 6
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Figure 7. FXN transcription is impaired in FRDA lymphoid cell lines.
FXN mRNA was analyzed in 3 control and 3 FRDA cell lines by qRT-PCR with primers
complementary to the exons 3 and 4. White bars designate control cell lines, while gray
bars designate FRDA cell lines. Each cell line has different textures. FXN expression was
normalized to the expression level determined for control GM15851 cells. The
experiment was conducted in triplicate. All data are expressed as mean ± SD. Permission
to re-use by Oxford University Press on behalf of the Nucleic Acids Research.

51

Figure 7

52

Distribution of histone modification at the FXN gene in the lymphoid
cell lines
To determine if the hyperexpanded GAA repeats might influence chromatin structures,
chromatin immunoprecipitation (ChIP) was used to examine histone modifications in the
lymphoid cell lines. Chromatin from the lymphoid cell lines was fragmented to obtain a
majority of chromatin fragment under 500 bp (Figure 8). All six lymphoid cell lines,
including three unaffected cells and three FRDA, were applied to examine each histone
modification in the following text and figures. Additionally, to demonstrate that the
hyperexpanded GAA repeats is sufficient to induce locally repressive chromatin
structure, I took advantage of the GFP_GAA reporter system that is engineered to harbor
560 GAA repeats at the GFP gene introduced into HEK293 cells. Each value in the ChIP
experiments discussed below is represented as the relative fold over total H3 of DNA
recovery against each histone modifications when normalized to total H3. Occupancy of
total H3 is not affected by the presence of the hyperexpanded GAA repeats in either the
lymphoid cell lines or the GFP_GAA system (Figure 9).

H3K9/14ac
To confirm the decreased levels of acetylation of histones at the FXN gene in FRDA
observed in other reports, I performed ChIP for H3K9/14ac in the lymphoid cell lines.
H3K9/14ac is well-known to be acetylated by GCN5 and p300/CBP-associated factor
(PCAF), chromatin remodelers, in eukaryotes (Bhaumik, 2011). Four primer sets were
used to define the distribution of H3K9/14ac at the FXN gene. I observed that the levels
of H3K9/14ac, when normalized for nucleosomal occupancy, were decreased at the FXN
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Figure 8. Fragmented chromatin extracted from the lymphoid cell lines and the
GFP_GAA reporter system.
Fragmented chromatin was detected using a 0.8% agarose gel. The majority of resulting
fragmentation is between 100 and 500 bp in length.
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Figure 8
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Figure 9. Hyperexpanded GAA repeats have no association with distribution of total
histone H3.
Total histone H3 in lymphoid cell lines and the GFP_GAA reporter system was
determined by ChIP. DNA from chromatin immunoprecipitated using antibodies specific
for total histone H3 was subjected to qPCR using primers amplifying (A) promoter
region, fragments upstream (Up) and downstream (Down) of the GAA repeats and
junction between intron 2 and exon 3 (In2Ex3) in the lymphoid cell liens, and (B)
Ex1/Int, a junction between exon 1 and the intron; Up, region upstream of the GAA
repeats; Down, region downstream of the GAA repeats; Int1/Ex2, a junction between the
intron and exon2 for the GFP_GAA reporter system. Total histone H3 levels are
normalized to 1% of the input (5x106 cells). White bars designate control cell lines, while
gray bars designate FRDA cell lines. Each cell line has different textures. No major
differences of total histone H3 distribution are observed at the entire FXN gene in the
lymphoid cell lines.
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gene in FRDA cell lines as expected. Specifically the levels of H3K9/14ac were the
lowest at the region upstream of the GAA repeats in FRDA cells when compared with
unaffected cells (Figure 10). On the contrary, in promoter region of the FXN gene, the
levels of H3K9/14ac were similar in both groups. This suggests that the hyperexpanded
GAA repeats are associated with repressive chromatin structure, but this structure dose
not extend to the promoter in FRDA cell lines.

H3K9me3
To add more evidence that the FXN gene in patients with FRDA has a repressive
chromatin structure, I examined levels of H3K9me3 at the FXN gene by ChIP (Figure
11). High levels of H3K9me3 are observed within heterochromatin such as is found at
centromeres (Wang, Schones and Zhao, 2009). This methylation is most likely associated
with silencing of gene expression. At the FXN gene, H3K9me3, when normalized for
nucleosomal occupancy, was greatly enriched in the region upstream of the GAA repeats
where lower levels of H3K9/14ac were observed in FRDA cell lines.

H4K20me3
Although H3K9me3 is preferentially enriched at heterochromatin, this histone
modification is also detected in the coding regions of transcriptionally active genes
(Vakoc, Mandat, Olenchock and Blobel, 2005). In centromeric region, enrichment of
H4K20me3 is accompanied by enrichment of H3K9me3
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Figure 10. H3K9/14ac is significantly repressed at the FXN gene in FRDA cells.
Distribution of H3K9/14ac at the FXN gene was defined by ChIP assay. DNA from
chromatin immunoprecipitated using antibodies specific for H3K9/14ac was subjected to
qPCR using primers amplifying promoter region, fragments upstream (Up) and
downstream (Down) of the GAA repeats and junction between intron 2 and exon 3
(In2Ex3). The experiment was conducted in triplicate using three FRDA and three
control cell lines. Data are expressed as mean ± SEM. P values were calculated by
comparing the averages of the relative fold over total H3 between unaffected and FRDA
lines. Levels of H3K9/14ac was significantly decreased in at the region upstream of the
GAA repeats in FRDA cells. Permission to re-use by Oxford University Press on behalf
of the Nucleic Acids Research.
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Figure 11. H3K9me3 is significantly increased at the FXN gene in FRDA cells.
Distribution of H3K9me3 at the FXN gene was defined by ChIP assay. The ChIP
experiment was conducted in triplicate using three FRDA and three control cell lines.
Data are expressed as mean ± SEM. The region upstream of the GAA repeats in FRDA
cells is enriched with levels of H3K9me3. Permission to re-use by Oxford University
Press on behalf of the Nucleic Acids Research.
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Figure 12. H4K20me3 is significantly increased at the FXN gene in FRDA cells.
Distribution of H4K20me3 at the FXN gene was defined by ChIP assay. The ChIP
experiment was conducted in triplicate using three FRDA and three control cell lines.
Data are expressed as mean ± SEM. The region upstream of the GAA repeats in FRDA
cells is enriched with levels of H4K20me3. Permission to re-use by Oxford University
Press on behalf of the Nucleic Acids Research.
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(Kourmouli, Jeppesen, Mahadevhaiah, Burgoyne, Wu, Gilbert, Bongiorni, Prantera,
Fanti, Pimpinelli, Shi, Fundele and Singh, 2004; Schotta, Lachner, Sarma, Ebert,
Sengupta, Reuter, Reinberg and Jenuwein, 2004). To ascertain whether high levels of
H3K9me3 at the FXN gene in FRDA cells are associated with the heterochromatin-like
structure induced by proximate regions of the hyperexpanded GAA repeats, I determined
the status of H4K20me3 at the FXN gene in FRDA and control cell lines (Figure 12). The
levels of H4K20me3, when normalized for nucleosomal occupancy, were the highest at
the region upstream of the GAA repeats in FRDA cell lines. The results of ChIP
experiments indicate that enrichment of H3K9me3 was associated with those of
H4K20me3 at the region upstream of the hyperexpanded GAA repeats in FRDA cells.
These data demonstrate that the region upstream of the hyperexpanded GAA repeats
facilitate a heterochromatin-like structure in FRDA cell lines.

H3K27me3
Repressive chromatin structures, such as the inactive X chromosome and silenced
inducible genes such as the bivalent gene, are frequently associated with enrichment of
H3K27me3 (Plath, Fang, Mlynarczyk-Evans, Cao, Worringer, Wang, de la Cruz, Otte,
Panning and Zhang, 2003; Seenundun, Rampalli, Liu, Aziz, Palii, Hong, Blais, Brand, Ge
and Dilworth, 2010). To further define change of chromatin configuration in the presence
of the hyperexpanded GAA repeats, I examined distribution of H3K27me3 at the FXN
gene in the lymphoid cell lines (Figure 13). ChIP assay revealed over representation of
H3K27me3, when normalized for nucleosomal occupancy, in the region upstream of the
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GAA repeats in FRDA cell lines, co-localizing with both H3K9me3 and H4K20me3
enrichment.

Taken together, I found that the expansion of GAA repeats induces a particular
constellation of histone modifications associated with heterochromatin-like structures at
the FXN gene in FRDA cells.
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Figure 13. H3K27me3 is enriched at the FXN gene in FRDA cells.
Distribution of H3K27me3 at the FXN gene was defined by ChIP assay. The ChIP
experiment was conducted in triplicate using three FRDA and three control cell lines.
Data are expressed as mean ± SEM. The region upstream of the GAA repeats in FRDA
cells is enriched with levels of H3K27me3. Permission to re-use by Oxford University
Press on behalf of the Nucleic Acids Research.
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Distribution of histone modification in the GFP_GAA reporter system
To investigate whether the alteration of histone modifications at the FXN gene results
from either inherent characteristics of the FXN gene or the hyperexpanded GAA repeats
per se, I used a GFP_GAA reporter system that harbors a single copy of the GFP reporter
gene containing 560 or 0 GAA repeats in the intron (Figure 14). I determined an effect of
integrated tract of the GAA repeats on transcription using qRT-PCR. Mature RNA of
GFP is decreased in the GFP_(GAATTC) 560 cells compared to the GFP_(GAATTC) 0
cells under the tetracycline treatment (Figure 15), indicating that the GFP_GAA system
genetically resembles FRDA.

To assess changes in chromatin structures caused by presence of longer GAA repeats in
the context of the GFP gene, I analyzed the distribution of histone modifications in the
vicinity of the GAA repeats in the GFP_GAA reporter system.

H3K9/14ac and H3K9me3
In order to validate that chromatin structure flanking the hyperexpanded GAA repeats has
characteristics of a heterochromatin-like structure, I examined distribution of H3K9/14ac
as a mark for open chromatin (Figure 16) and H3K9me3 as a mark for closed chromatin
in the GFP_GAA system (Figure 17). To further define whether the tract containing 560
GAA repeats has ability to bidirectionally spread across the GFP gene as characteristics
of heterochromatin, 2 more primer sets, a junction between exon1 and the intron and a
junction between the intron and exon 2 were used to perform qPCR following
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Figure 14. Validation of the presence of 560 GAA repeats in the GFP_GAA system.
The presence of 560 GAA repeats in the GFP_GAA reporter system repeats was
confirmed by conventional PCR. The region flanking 560 GAA repeats was amplified by
primer sets, Up and Down for the GFP gene listed in Table 1. The GFP_(GAATCC) 560
cells exhibit approximately 3Kb of PCR product, indicating that appropriate interstion
and maintenance of 560 GAA repeats at the GFP gene in the GFP_(GAATCC) 560 cells.
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Figure 15. GFP transcription is impaired in the GFP_(GAATCC) 560 cells.
GFP mRNA was analyzed in the GFP_GAA reporter system with primers
complementary to the exons 1 and exon 2. White bars designate control cell lines (the
GFP_(GAATCC) 0 cells), while gray bars designate the GFP_(GAATCC) 560 cells.
Each cell line has different textures. The experiment was conducted in triplicate. All data
are expressed as mean ± SD. Asterisk indicates statistical significance (p < 0.05). The
longer GAA repeats is associated with GFP deficiency in the GFP_(GAATCC) 560 cells.
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immunoprecipitation of chromatin against each histone modification. I confirmed
decreased levels of H3K9/14ac and increased levels of H3K9me3, when normalized for
nucleosomal occupancy, in the vicinity of the GAA repeats at the GFP gene in the
GFP_(GAATTC) 560 cells as shown in previous study (Soragni, Herman, Dent,
Gottesfeld, Wells and Napierala, 2008). Furthermore, I observed that both H3K9/14ac
and H3K9me3, when normalized for nucleosomal occupancy, extended up to the junction
between exon 1 and the intron as well as the junction between the intron and exon 2 of
the GFP gene in the GFP_(GAATTC) 560 cells. These results demonstrate that the
introduced GAA repeat induces condensed chromatin structures in the proximity of the
GAA repeats. Moreover, these results suggest that the hyperexpanded tract of GAA
repeats per se has the ability to induce spreading of condensed chromatin structures.
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Figure 16. H3K9/14ac is significantly decreased at the GFP gene in the presence of
GAA repeats.
Upon tetracycline treatment, the levels of H3K9/14ac in the GFP_GAA reporter system
were determined by ChIP assay. White bars represent the GFP_(GAATTC) 0 cells. Gray
bars represent the GFP_(GAATTC) 560 cells. Data are expressed as mean ± SEM.
Asterisk indicates statistical significance (one: p < 0.05, two: p < 0.01, three: p < 0.001).
The abundance of histone modifications is shown relative to input DNA in the PCR and
normalized to a total H3 for each region. Levels of H3K9/14 are less enriched at the
entire GFP gene in the GFP_(GAATTC) 560 cells relative to the GFP_(GAATTC) 0
cells. Permission to re-use by Oxford University Press on behalf of the Nucleic Acids
Research.
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Figure 17. H3K9me3 is enriched at the GFP gene in the presence of longer GAA
repeats.
The levels of H3K9me3 in the GFP_GAA reporter system were determined in active
transcription. White bars represent the GFP_(GAATTC) 0 cells. Gray bars represent the
GFP_(GAATTC) 560 cells. Data are expressed as mean ± SEM. Asterisk indicates
statistical significance (one: p < 0.05, two: p < 0.01, three: p < 0.001). The abundance of
histone modifications is shown relative to input DNA in the PCR and normalized to a
total H3 for each region. H3K9me3 are significantly increased in the GFP_(GAATTC)
560

cells. Permission to re-use by Oxford University Press on behalf of the Nucleic Acids

Research.
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Chapter 4. Determination of the effect of the GAA repeats in
transcription in the context of chromatin structure

Some parts of this dissertation were modified from the following journal article:
Eunah Kim, Marek Napierala, Sharon Y.R. Dent. Hyperexpansion of GAA repeats
affects post-initiation steps of FXN transcription in Friedreich’s ataxia, Nucleic Acids
Research (2011) July.
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In lymphoid cell lines
FXN transcription in lymphoid cells
In order to assess the effect of the hyperexpanded GAA repeats on the transcription
progression at the FXN gene, I examined levels of FXN pre-mRNA in one upstream
(from +1231 to +1344 within the intron 1) and in three regions downstream (variable
positions, depending on repeat tract length) of the GAA repeats (Figure 18). Importantly,
all primers pairs used in this experiment recognize FXN pre-mRNA to avoid a bias from
the FXN mRNA. I found that levels of FXN pre-mRNA at the region upstream of the
hyperexpanded GAA repeats have no differences in all three unaffected control cell lines
and two of the three FRDA lymphoid cell lines. The GM16798 cell line exhibited a lower
level of the FXN pre-mRNA upstream of the GAA repeats as compared to the remaining
five cell lines. The GM16798 also exhibited the lowest expression of FXN mRNA
(Figure 7). Additionally, FRDA patient from whom the GM16798 cell line was derived
reported the earliest onset of the disease (5 yr vs. 10 and 11 yrs for the other FRDA
individuals). In contrast to the similar levels of FXN pre-mRNA upstream of the GAA
repeats, levels of FXN pre-mRNA downstream of the GAA repeats were reduced
approximately 4-fold in all three FRDA lymphoid cell lines compared to unaffected cell
lines. This result suggests that levels of the FXN pre-mRNA downstream expression are
tightly associated with the pathology of FRDA.
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Figure 18. FXN deficiency appears at the region downstream of the hyperexpanded
GAA repeats in FRDA cells.
Relative level of FXN pre-mRNA was determined in various regions of the transcript.
One ‘Up’ and three ‘Down’ primers amplify regions in the immediate vicinity of the
GAA repeats. In1Ex2 and In2Ex3 anneal to the junctions between the corresponding
introns and exons of FXN pre-mRNA. White bars designate control cell lines, while gray
bars designate FRDA cell lines. Each cell line has different textures. FXN pre-mRNA
expression was normalized to the level of the fragment amplified upstream of the GAA
region in the control GM15851 cells. The experiment was performed in triplicate. The
region downstream transcript is significantly decreased in FRDA cells compared to
unaffected cells. Permission to re-use by Oxford University Press on behalf of the
Nucleic Acids Research.
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Distribution of total RNA pol II at the FXN gene
Gene expression is dependent on the accessibility of the DNA sequences to RNA
polymerase, transcription factors, and chromatin remodeling complexes. In an effort to
further investigate how the hyperexpanded GAA repeats influence progression of FXN
transcription, I analyzed the distribution of total RNA pol II at the FXN gene by ChIP
assay (Figure 19). Immunoprecipitation of total RNA pol II include both
unphosphorylated and phosphorylated forms of the large subunit of RNA pol II. Seven
primer sets were used to map the distribution of RNA Pol II in the FXN gene. Based on
prior studies showing transcriptional pausing in the proximity of the long GAA tracts in
in vitro and in cell culture system (Grabczyk and Usdin, 2000b; Krasilnikova, Kireeva,
Petrovic, Knijnikova, Kashlev and Mirkin, 2007), I expected that RNA pol II progression
would be inhibited in the region upstream of the GAA repeats, resulting in accumulation
of transcriptional machinery in the region upstream of the GAA repeats in FRDA cell
lines. However, I detected repressed levels of RNA pol II across the entire FXN gene in
FRDA cell lines relative to unaffected cell lines. Importantly, levels of RNA pol II were
not significantly changed at promoter region (from -242 to -12) in FRDA cell lines
compared to unaffected cell lines, suggesting that FXN promoter activity is not affected
in FRDA cell lines. These results correlate with similar levels of FXN pre-mRNA
upstream of the GAA repeats observed in both FRDA and unaffected control cell lines as
shown in Figure 17.

Interestingly, RNA pol II is mostly enriched at a FXN promoter-proximal region (from
+48 to +150) in unaffected cell lines, even though a number of the GAA repeats is short
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Figure 19. Distribution of total RNA pol II is repressed at the FXN gene in FRDA
cells.
Level of total RNA pol II was determined by immunoprecipitating the large subunit of
RNA pol II in FRDA and unaffected cells. Average occupancy of RNA pol II across the
FXN gene in all three FRDA and three control cells is shown using gray circles and black
squares, respectively. The position of the first nucleotide for the forward primer relative
to transcription start site (TSS) is indicated below the X axis. The specificity of RNA pol
II antibody for ChIP was verified by RNA pol II pausing at the +55 bp of the GAPDH
gene. Error bars represent standard error of the mean. The experiment was conducted in
triplicate using three FRDA and three control cell lines. The P value was generated by
comparing the average % Input of total RNA pol II between unaffected and FRDA
lymphoid cell lines. Permission to re-use by Oxford University Press on behalf of the
Nucleic Acids Research.
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in these cells. The accumulation at (+) 48 bp is significant as compared to either (-)242
bp or (-)133 bp (p < 0.05). This phenomenon is also observed in some genes as shown at
the GAPDH gene (Guenther, Levine, Boyer, Jaenisch and Young, 2007), where RNA pol
II is known to pause. No RNA pol II Pausing was detected in the FRDA cell lines. These
results suggest that defective transcriptional in FRDA cells originate at a post-initiation
step of FXN transcription, which result in decreased enrichment of the transcription
machinery at the promoter-proximal region as well as throughout the FXN gene.

H3K4me2 and H3K4me3
To investigate changes of active chromatin structure caused by the hyperexpanded GAA
repeat, histone modifications relative to active chromatin structures was examined by
ChIP in the lymphoid cell lines. As indicators of active transcription initiation, levels of
both H3K4me2 and H3K4me3 exhibit a peak at transcription start site (TSS) of a given
gene that is recently transcribed. Although H3K4me2 and H3K4me3 levels varied among
lymphoid cell lines, levels of H3K4me2 and H3K4me3, when normalized for
nucleosomal occupancy, were not changed at the promoter region (from –138 to –12) of
the FXN gene in FRDA cell lines relative to unaffected controls (Figure 20 and Figure
21). These results are correlated with our quantitative FXN pre-mRNA analyses showing
similar levels of FXN pre-mRNA upstream of GAA repeats in both unaffected and FRDA
cell lines. Interestingly, H3K4me2 and H3K4me3 were significantly diminished at a
region upstream of the GAA repeats (from +1228 to +1344) of the FXN gene in FRDA
cell lines, while levels of H3K4me2 and H3K4me3 cells, when normalized for
nucleosomal occupancy, were increased at this region in the unaffected cells. Enrichment
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Figure 20. H3K4me2 is decreased at the region upstream of the GAA repeat, not
promoter region in FRDA cells.
Distribution of H3K4me2 at the FXN gene was defined by ChIP assay. The ChIP
experiment was conducted in triplicate using three FRDA (gray bars) and three control
cell lines (white bars). Each cell line has different texture. Data are expressed as mean ±
SEM. Levels of H3K4me2 are decreased at the region upstream of the GAA repeat in
FRDA cell, while unaffected show great levels of H3K4me2. No differences of
H3K4me2 were detected in both FRDA and unaffected cells. Permission to re-use by
Oxford University Press on behalf of the Nucleic Acids Research.
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Figure 21. Levels of H3K4me3 are not affected at promoter region in FRDA cells.
Distribution of H3K4me3 at the FXN gene was defined by ChIP assay. The ChIP
experiment was conducted in triplicate using three FRDA (gray bars) and three
unaffected cell lines (white bars). Each cell line has different texture. Data are expressed
as mean ± SEM. Levels of H3K4me3 are not changed at promoter region in FRDA cells
compared to unaffected cells. However, H3K4me3 is decreased at the region upstream of
the GAA repeats in FRDA cells compared to unaffected cells. Permission to re-use by
Oxford University Press on behalf of the Nucleic Acids Research.
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of H3K4me2 has been associated with non-methylated CpG residues more tightly than
transcriptional activity (Okitsu and Hsieh, 2007; Okitsu, Hsieh and Hsieh). In previous
studies from other groups, increased levels of DNA methylation in the region upstream of
the GAA repeats have been reported in FRDA cell lines relative to unaffected cells
(Castaldo, Pinelli, Monticelli, Acquaviva, Giacchetti, Filla, Sacchetti, Keller,
Avvedimento, Chiariotti and Cocozza, 2008; Greene, Mahishi, Entezam, Kumari and
Usdin, 2007). Thus, the lower levels of H3K4me2 at the region upstream of the GAA
repeats in FRDA cell lines could imply hyper DNA methylation, particularly at this
region in FRDA patients. Enrichment of H3K4me3 in coding regions is associated with
the efficient transition between initiation and elongation of transcription during ongoing
transcription (Sims, Millhouse, Chen, Lewis, Erdjument-Bromage, Tempst, Manley and
Reinberg, 2007). Therefore, the decreased levels of H3K4me3 in FRDA cell may reflect
that the hyperexpanded GAA repeats influence the efficiency of post-initiation of FXN
transcription.

To further examine whether levels of H3K4me3 at the region upstream of GAA repeats
in unaffected cells is associated with the activity of transcription elongation rather than
transcription initiation, I measured levels of H3K4me3 upon inhibition of transcription
elongation by D-ribofuranosylbenzimidazole (DRB) (Figure 22). DRB, a pharmacologic
inhibitor of CDK9, decreases RNA pol II phosphorylation at Serine-2, a hallmark feature
of the elongating form of RNA pol II during transcription. Following DRB treatment, the
control cell line (GM15851) exhibited a significant decrease of H3K4me3 at the region
upstream of the GAA repeats, which was very similar to that observed in FRDA cell line
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Figure 22. H3K4me3 at the region upstream of the GAA repeats in FRDA cells is
associated with impared FXN transcription elongation.
H3K4me3 distribution were determined by ChIP assay upon inhibition of transcription
elongation (50 µM DRB for 5 hr). The ChIP experiment was conducted in twice using
one FRDA cell (gray bars: GM15850) and one unaffected cell line (white bars:
GM15851). Data are expressed as mean ± SEM. H3K4me3 is decreased at the region
upstream of the GAA repeats in FRDA cells upon inhibition of transcription elongation.
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Figure 22
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(GM15850), when normalized for nucleosomal occupancy. This result suggests that the
levels of H3K4me3 at the region upstream of the GAA repeats are associated with
transcription elongation rather than transcription initiation. Taken together, these results
suggest that the hyperexpanded GAA repeat does not affect chromatin structures at the
FXN promoter region but does result in impaired elongation of FXN transcription in
FRDA.

H3K36me3 and H3K79me2
To further understand the effect of the hyperexpanded GAA repeats on the transcription
process throughout the FXN gene, I examined the levels of H3K36me3 and H3K79me2,
indicators of transcription elongation (Figure 23 and Figure 24). Increasing enrichment of
H3K36me3 to the 3’-end of a gene is indicating ongoing transcription elongation. In
unaffected cell lines, H3K36me3 levels, when normalized for nucleosomal occupancy,
progressively increased toward the 3’-end of the FXN gene. However, enrichment of
H3K36me3 was repressed across the FXN gene in FRDA cell lines. The distribution of
H3K36me3 is consistent with total RNA pol II progression shown in Figure 19. These
results indicate defective transcription elongation of the FXN gene in FRDA cell lines. A
genome-wide study revealed that enrichment H3K79me2 at regions downstream of the
TSS accompanying with H3K4me3 at the TSS is associated with full-length transcripts of
genes (Kanhere, Viiri, Araujo, Rasaiyaah, Bouwman, Whyte, Pereira, Brookes, Walker,
Bell, Pombo, Fisher, Young and Jenner, 2010). In contrast, enrichment of H3K4me3
alone is feature for genes that experience transcription initiation alone, without elongation
(Rahl, Lin, Seila, Flynn, McCuine, Burge, Sharp and Young, 2010). I found that
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H3K79me2, when normalized for nucleosomal occupancy, were dramatically decreased
throughout the FXN gene in FRDA cells, while H3K79me2 is pronounced in the vicinity
of the GAA repeats in the unaffected control cells. As shown in Figure 20, since
enrichment of H3K4me3 has no differences at the FXN promoter region in FRDA cell
lines compared to unaffected cells, these results further support the that FXN deficiency
in FRDA cells results from defective elongation step of FXN transcription after
successful initiation.

95

Figure 23. H3K36me3 are repressed at the entire FXN gene in FRDA cells relative
to unaffected cells.
Distribution of H3K36me3 at the FXN gene was defined by ChIP assay. The ChIP
experiment was conducted in triplicate using three FRDA (gray bars) and three
unaffected cell lines (white bars). Each cell line has different texture. Data are expressed
as mean ± SEM. Levels of H3K36me3 are decreased at the entire FXN gene in FRDA
cells, while they are gradually increased toward 3’ end of the FXN gene in unaffected
cells. Permission to re-use by Oxford University Press on behalf of the Nucleic Acids
Research.
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Figure 23
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Figure 24. H3K79me2 is significantly decreased in FRDA cells.
Distribution of H3K79me2 at the FXN gene was defined by ChIP assay. The ChIP
experiment was conducted in triplicate using three FRDA (gray bars) and three
unaffected cell lines (white bars). Each cell line has different texture. Data are expressed
as mean ± SEM. Levels of H3K79me2 are decreased at the entire FXN gene in FRDA
cells, while they are enriched in the vicinity of the GAA repeats at the FXN gene in
unaffected cells. Permission to re-use by Oxford University Press on behalf of the
Nucleic Acids Research.
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In the GFP_GAA system
H3K4me3 and H3K79me2
To further investigate the effect of the presence of the GAA repeats in progression of
transcription independently of FXN promoter or FXN intronic sequences, I examined
enrichments of H3K4me3 (transcription initiation) and H3K79me2 (transcription
elongation) at the GFP gene in the GFP_GAA reporter system using ChIP assay when
normalized for nucleosomal occupancy (Figure 25 and Figure 26). Levels of H3K4me3
were not changed at the region upstream of the GAA repeats including a junction
between exon 1 and the intron and the region upstream of the GAA repeats (named ‘Up’)
in the GFP_(GAATTC) 560 cells compared to the GFP_(GAATTC) 0 cells that lack the
GAA repeats. However, H3K4me3 levels were significantly decreased in the region
downstream of the GAA repeats in the GFP_(GAATTC) 560 cells. This distribution of
H3K4me3 at the GFP gene in GFP_(GAATTC) 560 cells is comparable to that found at
the FXN gene in the FRDA cell lines. In addition, I found that enrichment of H3K79me2
was significantly decreased at the region downstream of the GAA repeats at the GFP
gene in the GFP_(GAATTC) 560 cells when compared to the corresponding region in the
GFP_(GAATTC) 0 cells. These results clearly show that the presence of the
hyperexpanded GAA repeats not only stimulate epigenetic changes in the proximate
chromatin independently of the DNA context, but also are sufficient to impede
transcription elongation. More importantly, the observations of histone modification
showing impediment of transcription elongation in the GFP_(GAATTC) 560 cells,
without affecting initiation, is consistent with alteration of histone modifications
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Figure 25. H3K4me3 is affected at the region downstream of the GAA repeats in the
presence of the GAA repeats.
The levels of H3K4me3 in the GFP_GAA reporter system were determined by ChIP
assay. White bars represent the GFP_(GAATTC) 0 cells. Gray bars represent the
GFP_(GAATTC) 560 cells. Data are expressed as mean ± SEM. Asterisk indicates
statistical significance (p < 0.05). The abundance of histone modifications is shown
relative to input DNA in the PCR and normalized to a total H3 for each region. Upon
tetracycline treatment, H3K4me3 are affected at the region downstream of the GAA
repeats in the GFP_(GAATTC) 560 cells compared to the GFP_(GAATTC) 0 cells.
Permission to re-use by Oxford University Press on behalf of the Nucleic Acids
Research.
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Figure 26. H3K79me2 is affected at the region downstream of the GAA repeats in
the GFP_(GAATTC) 560 cells.
The levels of H3K79me2 in the GFP_GAA reporter system were determined by ChIP
assay. White bars represent the GFP_(GAATTC) 0 cells. Gray bars represent the
GFP_(GAATTC) 560 cells. Data are expressed as mean ± SEM. Asterisk indicates
statistical significance (one: p < 0.05, three: p < 0.001). The abundance of histone
modifications is shown relative to input DNA in the PCR and normalized to a total H3 for
each region. Upon tetracycline treatment, H3K79me3 are decreased at the region
upstream of the GAA repeats in the GFP_(GAATTC) 560 cells compared to the
GFP_(GAATTC) 0 cells. Permission to re-use by Oxford University Press on behalf of
the Nucleic Acids Research.
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observed in FRDA cell lines. These results strongly suggest that elongation is the major
step hampered by the hyperexpanded GAA repeats in FRDA patients.

Longer GAA repeats is associated with inhibiting progression of RNA polymerases in in
vitro and in vivo systems (Grabczyk and Usdin, 2000b; Krasilnikova, Kireeva, Petrovic,
Knijnikova, Kashlev and Mirkin, 2007). Moreover, transcription arrest is associated with
alteration of histone modifications (Balakrishnan and Milavetz, 2007; Li, Carey and
Workman, 2007; Nagata, Ito, Arimitsu, Koyama and Sekimizu, 2009). To assess whether
RNA pol II arrest associated with the presence of the GAA repeats can prompt the
cascade of silencing events, I used the GFP_GAA reporter system allowing us to
precisely control initiation of transcription using tetracycline regulated operator/repressor
(Figure 27). Generally, the GFP_GAA reporter system has been cultured in the absence
of tetracycline to maintain cell lines. Both the GFP_(GAATTC) 560 and the
GFP_(GAATTC) 0 cells were sub-cultured for less than 10 passages prior to the
tetracycline treatment. In order to investigate the effect of transcription in alteration of
histone modifications by the hyperexpanded GAA repeats, the cells were prepared in
parallel in the absence or presence of the tetracycline. Upon the absence of tetracycline to
inhibit transcription, levels of H3K9me3 were pronounced in regions both upstream and
downstream of the GAA repeats in the GFP_(GAATTC) 560 cells, not the
GFP_(GAATTC) 0 cells. After initiation of transcription by the tetracycline treatment,
no significant changes of H3K9me3 levels were observed in the proximity of the GAA
repeats in the GFP_(GAATTC) 560 cells when compared to the GFP_(GAATTC) 560
cells that is not treated with tetracycline. However, enrichments of H3K79me2 were
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dramatically reduced at the region downstream of the GAA repeats in the
GFP_(GAATTC) 560 cells upon inhibition of transcription as I expected. This result
strongly suggests that the hyperexpanded GAA repeats per se are the underlying cause of
the heterochromatin-like structure formation and the arrest of RNA pol II is unlikely to
serve as a signal instigating epigenetic changes associated with the longer GAA repeats.
Taken together, my results demonstrate that insufficient levels of FXN expression in
FRDA patients are a consequence of impeded transcription elongation through the
heterochromatin-like structure induced by the hyperexpanded GAA repeats.
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Figure 27. The tract of GAA repeats is sufficient to form the heterochromatin-like
structure in the absence of transcription, which lead to inhibition of transcription
elongation.
Effect of transcription on the formation of the heterochromatin-like structure was
analyzed using ChIP assay in the GFP_GAA reporter system. Enrichment of H3K9me3
and H3K79me2 at the region upstream (Up) and the region downstream (Down) were
determined in the absence and presence of tetracycline (0.1 µg/mL for 24 h). White bars
represent results obtained from cell line lacking the GAA repeats in intron of the GFP
gene while gray bars representing cells harboring intronic 560 of GAAs. Data are
expressed as mean ± SEM. The experiment was conducted in triplicate and P values were
calculated from the average of all three determinations for the GFP_(GAATTC) 560 and
the GFP_(GAATTC) 0 cells. H3K9me3 is enriched in the GFP_(GAATTC) 560 in the
absence and presence of tetracycline. H3K79me2 are impaired in the GFP_(GAATTC)
560

upon tetracycline treatment to resume transcription. Permission to re-use by Oxford

University Press on behalf of the Nucleic Acids Research.
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Figure 27
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Chapter 5. Discussion

Some parts of this dissertation were modified from the following journal article:
Eunah Kim, Marek Napierala, Sharon Y.R. Dent. Hyperexpansion of GAA repeats
affects post-initiation steps of FXN transcription in Friedreich’s ataxia, Nucleic Acids
Research, (2011) 39(19): 8366-8377.
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In my study, defining altered histone modifications and repressive RNA pol II
distribution at the FXN gene in FRDA cell lines provides strong evidence that FXN
insufficiency in FRDA cell lines begin at a post-initiation step of FXN transcription. I
also detected an accumulation of total RNA pol II at the promoter-proximal region of the
FXN gene in unaffected cells, but not in FRDA cells. Several studies using genome-wide
analysis have suggested that post-initiation events are rate-limiting to regulate
transcription of some genes (Guenther, Levine, Boyer, Jaenisch and Young, 2007;
Saunders, Core and Lis, 2006). This phenomenon is well-described for a heat shock–
inducible gene, Hsp70, in Drosophila (Gilmour and Lis, 1986). Increased levels of RNA
pol II are observed at the promoter of the Hsp70 gene upon uninduced condition, and this
RNA pol II is released from the promoter by heat shock stimuli, leading to launching of
Hsp70 transcription (Gilmour and Lis, 1986). Genome-wide analysis of transcripts using
nuclear run-on assay reveals paused Pol II on a large number of genes in human cells
(Core, Waterfall and Lis, 2008). This phenomenon prompts me to hypothesize that FXN
gene may be categorized as an inducible gene that is regulated by tissue-specific factors.
The FXN gene is positively regulated by two transcription factors, peroxisome
proliferator-activated receptor (PPAR) gamma and hypoxia-inducible factor-2 alpha
(Marmolino, Acquaviva, Pinelli, Monticelli, Castaldo, Filla and Cocozza, 2009; Oktay,
Dioum, Matsuzaki, Ding, Yan, Haller, Szweda and Garcia, 2007). PPAR gamma is more
highly expressed in FRDA cells compared to unaffected individuals (Marmolino,
Acquaviva, Pinelli, Monticelli, Castaldo, Filla and Cocozza, 2009). Imbalance of iron as
detected in FRDA patients may also affect the induction of FXN expression, as proposed
in a previous study (Li, Besse, Ha, Kovtunovych and Rouault, 2008). The longer GAA
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repeats at the FXN gene in FRDA patient may recruit particular factors that inhibit
induction of FXN expression. In contrast, non-B DNA structure adopted by the longer
GAA repeat per se may inhibit to recruit particular factors that induce of FXN
expression.

According to my results, paused RNA pol II is unlikely to reflect ongoing transcription,
at least at the FXN gene. Although FXN pre-mRNA levels are similar in both
unaffected and FRDA cells, total RNA pol II, as measured by ChIP, only accumulates at
the promoter-proximal region of the FXN gene in FRDA cells. Moreover, this
accumulation is restricted to the promoter-proximal region, not other regions including
promoter. Therefore, FXN pre-mRNA seems to reflect FXN promoter activity more than
chromatin structure at the region This finding is consistent with those of a previous
study that indicated promoter activity is not affected at the FXN gene in FRDA cells,
although altered histone modifications were observed at the promoter-proximal region
(Kumari, Biacsi and Usdin, 2011b). In an effort to confirm correlation between the levels
of RNA pol II and FXN transcription, I tried to measure pre-mature FXN RNA at the
promoter-proximal region (+48bp). Unfortunately, the FXN promoter-proximal region is
quite CG-rich, so that qRT-PCR assays were not successful. Both H3K4me2 and
H3K4me3 are greatly decreased at this region in FRDA cells when compared to
unaffected cells. This result suggests that the paused RNA pol II at the promoterproximal region in unaffected cells may facilitate chromatin remodeling for euchromatin
as shown in my results to trigger additional transcription progression. The paused RNA
pol II may help to stabilize the binding of transcription machinery assisting further
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rounds of transcription initiation. Indeed, the accumulated RNA pol II in the promoterproximal region is associated with the enrichment of active histone marks such as
H3K9/14ac and H3K4me3 in the human genome, regardless of transcription status
(Guenther, Levine, Boyer, Jaenisch and Young, 2007). FRDA cells exhibit a slow rate of
FXN mRNA synthesis when compared to unaffected cell lines (Punga and Buhler, 2010).

The decreased levels of RNA pol II in the coding region of genes is associated with
decreased levels of H3K4me2 and H3K4me3, hyper-methylated CpG residues, and
increased levels of H3K9me (Okitsu and Hsieh, 2007; Okitsu, Hsieh and Hsieh, 2010).
Consistently, levels of total RNA pol II is repressed in the region upstream of the GAA
repeats in FRDA cells compared to unaffected cells. Moreover, the region upstream of
the GAA repeats display less enrichment of H3K4me3 and H3K4me2 in FRDA cells
compared to unaffected cells. Enrichment of H3K4me3 in the coding region of genes is
associated with the efficiency of transition between initiation and elongation in
transcription (Okitsu and Hsieh, 2007; Okitsu, Hsieh and Hsieh, 2010), and contributes to
recruit chromatin-remodeling complexes (Li, Ilin, Wang, Duncan, Wysocka, Allis and
Patel, 2006; Sims, Millhouse, Chen, Lewis, Erdjument-Bromage, Tempst, Manley and
Reinberg, 2007). Therefore, the decreased levels of H3K4me3 at the region upstream of
GAA repeats in FRDA cells may impair recruitment of chromatin-modifying complexes
or lead to FXN deficiency resulting from impediment of FXN transcription elongation in
FRDA patients.

Histone methylation status represents both an important regulatory element of gene
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expression and an indicator of the transcriptional status of a gene. Enzymes that add or
remove methyl groups on specific sites of histones regulate the balance between
methylation and demethylation in the cells. Activity of a large group of histone
demethylases containing Jumonji C-terminal domain depends on the presence of nonheme iron (Hahn, Bose, Edler and Lengeling, 2008). Several reports show that low levels
of FXN, an iron chaperone, results in accumulated irons in the mitochondria and depleted
iron in the other cellular compartments leading to a severe imbalance of iron in FRDA
cells (Adinolfi, Iannuzzi, Prischi, Pastore, Iametti, Martin, Bonomi and Pastore, 2009;
Bulteau, O'Neill, Kennedy, Ikeda-Saito, Isaya and Szweda, 2004). This suggests that the
imbalance of iron in FRDA patients may be associated with the activity of irondependent demethylases responsible for levels of H3K27me3. In FRDA cells, compared
to controls, I detected significant increase of H3K27me3, histone methylation marks
potentially affected by iron-dependent histone demethylases such UTX. Indeed, over
expression of UTX increases expression of FXN mRNA in KYSE180 cancer cells (van
Haaften, Dalgliesh, Davies, Chen, Bignell, Greenman, Edkins, Hardy, O'Meara, Teague,
Butler, Hinton, Latimer, Andrews, Barthorpe, Beare, Buck, Campbell, Cole, Forbes, Jia,
Jones, Kok, Leroy, Lin, McBride, Maddison, Maquire, McLay, Menzies, Mironenko,
Mulderrig, Mudie, Pleasance, Shepherd, Smith, Stebbings, Stephens, Tang, Tarpey,
Turner, Turrell, Varian, West, Widaa, Wray, Collins, Ichimura, Law, Wong, Yuen,
Leung, Tonon, DePinho, Tai, Anderson, Kahnoski, Massie, Khoo, Teh, Stratton and
Futreal, 2009). Moreover, genome-wide approach reveals that FXN deficiency is
associated with down regulation of genes involved in DNA packaging and nucleosome
assembly (Huang, Becker, Whitnall, Rahmanto, Ponka and Richardson, 2009).
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In an effort to alleviate transcriptional block facilitated by the GAA repeat expansions in
FRDA patients, dissecting the mechanism of heterochromatin-like structure induced by
the hyperexpanded GAA repeats is critical for logical design of therapeutic approaches.
Currently, HDACis are the most promising small molecules that restore FXN
transcription and alter the chromatin status in the proximity of the GAA repeats, but not
the promoter region of the FXN gene in FRDA cells (Herman, Jenssen, Burnett, Soragni,
Perlman and Gottesfeld, 2006). However, the question of either the initial event or the
cascade of epigenetic changes in the GAA repeats region remains to be addressed.
Perhaps the hyperexpanded GAA repeats per se or non-B DNA structures facilitated by
the hyperexpanded GAA repeats employ particular proteins that affect modifications on
histones in the chromatin environment in the vicinity of the GAA repeats. Moreover,
paused RNA pol II at the c-Myc gene is observed in the vicinity of a triplex forming
repeat structure (Belotserkovskii, De Silva, Tornaletti, Wang, Vasquez and Hanawalt,
2007), suggest that non-canonical DNA structures induced by the hyperexpanded GAA
repeats might be a primary origin of deficient FXN transcription in FRDA.

In fission yeast and Drosophila, and possibly other eukaryotes, the RNA interference
(RNAi) pathway is involved in heterochromatin formation (Wassenegger, 2005).
Endogenous short interfering RNA (siRNA) originates from repetitive sequences such as
centromeric repeats, transposable elements or rDNA and act as a trigger the RNAi
pathway (Fagegaltier, Bouge, Berry, Poisot, Sismeiro, Coppee, Theodore, Voinnet and
Antoniewski, 2009). A genome-wide approach revealed that there are antisense
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transcripts at the FXN locus in humans (He, Vogelstein, Velculescu, Papadopoulos and
Kinzler, 2008). Recently, more antisense transcripts (FAST-1) were observed in the
proximity of TSS of the FXN gene in FRDA cells (De Biase, Chutake, Rindler and
Bidichandani, 2009). Antisense FXN transcripts can be involved in prompting silencing
of FXN transcription via RNAi-mediated heterochromatin formation through double
stranded RNA generated from repetitive DNA sequences. In an effort to assess the
relative contribution of antisense FXN transcripts in regulation of FXN expression, we
also performed strand-specific RT-PCR to detect antisense transcription in the FXN
locus. Unfortunately, we were unable to detect antisense transcripts at the regions
specified in the previous study, the proximity of TSS of the FXN gene as well as region
upstream of the GAA repeats (data not shown). Therefore, all FXN transcripts examined
in this study represent sense FXN RNA transcripts.

, Most diseases assocated with repetitive DNA sequences exhibit distinct patterns of
repetitive element instability in neuronal as compared to non-neuronal cells (Pearson,
Nichol Edamura and Cleary, 2005). Indeed, although GAA contractions occur in all
tissues, expansions occur only in the brain of FRDA patients (Cleary and Pearson, 2003).
The tissue specificity could contribute to disease progression (Swami, Hendricks, Gillis,
Massood, Mysore, Myers and Wheeler, 2009). DNA metabolism such as replication,
repair, recombination and transcription, is important for instability of the repetitive DNA
unit. Notably, abnormal function of mismatch repair proteins, such as MSH2, is
associated with GAA instability in yeast (Shishkin, Voineagu, Matera, Cherng, Chernet,
Krasilnikova, Narayanan, Lobachev and Mirkin, 2009) and in inducible pluripotent stem
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(iPS) cells from FRDA patients (Ku, Soragni, Campau, Thomas, Altun, Laurent, Loring,
Napierala and Gottesfeld, 2010). Similar to FRDA, base excision repair factors are
associated with CTG repeat stability (Liu, Prasad, Beard, Hou, Horton, McMurray and
Wilson, 2009). Tissue specific levels of these trans-acting factors may contribute to
increased instability of repetitive DNA sequence in neuronal cells of the patients. Also,
cis-elements, such as the CTCF DNA binding motif, are associated with tissue and
developmental specificity of increased repeat instability (Pearson, Nichol Edamura and
Cleary, 2005). CTCF DNA binding motifs flank numerous genes that contain repetitive
DNA units and are known to modulate chromatin structure and transcription in several
neurological disorders (Chang, Zhang, Heath, Galjart, Wang and Milbrandt, 2010;
Pearson, Nichol Edamura and Cleary, 2005). Methylation of cytosine or mutation of
CTCF-binding motif at the SCA7 locus inhibits CTCF binding, thereby increasing tissue
specific repeat instability in SCA7 (CAG repeats) (Libby, Hagerman, Pineda, Lau, Cho,
Baccam, Axford, Cleary, Moore, Sopher, Tapscott, Filippova, Pearson and La Spada,
2008). In FRDA, more CTCF occupancy are accompanied with heterochromatinized
structures at the FXN genes, which lead to transcribe antisense FXN RNAs (De Biase,
Chutake, Rindler and Bidichandani, 2009). However, distinct levels of CTCF in neuronal
cells have not yet been reported in neurodegenerative diseases affected by repetitive
DNA sequences. Moreover, occupancy of CTCF is not correlated with overt transcription
in mammals (Splinter, Heath, Kooren, Palstra, Klous, Grosveld, Galjart and de Laat,
2006). This suggests that upstream tissue-specific factors that regulate CTCF may
contribute to tissue specificity of repeat instability. Methylations at the promoter of the
BDNF gene, a growth factor that plays important roles in regulating neurogenesis,
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synaptic plasticity, and neuronal survival, are associated with neurodegenerative
disorders, including Huntingtons disease (Zuccato and Cattaneo, 2009).
Hypermethylated CpG residues in the BDNF gene in the cortical neuron in
neurodegenerative conditions inhibits CTCF binding leading to silence of BDNF
expression (Chang, Zhang, Heath, Galjart, Wang and Milbrandt, 2010). This report may
shed light on the mechanistic relationship between pathology of neurodegenerative
diseases and repeat instability in neuronal cell types.

Moreover, CTCF is associated with chromatin looping and altered histone modifications
(Splinter, Heath, Kooren, Palstra, Klous, Grosveld, Galjart and de Laat, 2006). I found
that pausing of RNA pol II occurred at the promoter-proximal region, not the region
upstream of the GAA repeat at the FXN gene. This phenomenon might suggest looping of
the chromosome from the TSS to a region upstream of the GAA repeats at the FXN gene
in FRDA cells. The hyperexpanded GAA repeats influence the looping in FRDA cells,
thereby affect not only chromatin structure but also FXN transcription. In reconstitution
assays, nucleosomes are less well assembled into double stranded DNA sequences
containing longer GAA repeats (Ruan and Wang, 2008). The hyperexpanded GAA
repeat that have less nucleosome assembly might have higher opportunity to be looped
between TSS and the region immediately upstream of the GAA repeats, thereby affecting
configuration of chromatin structure and distribution of RNA pol II at the FXN gene in
FRDA cells.
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Expansions of repetitive DNA sequences are correlated with human neurological and
neuromuscular diseases. To date, at least 15 neurodegenerative disorders are identified as
the repeats-expansion diseases (Wells, 1996). These lengths of repetitive DNA unit are
dynamic in among individuals, generations, and tissues of the patients. There are many
evidences that these repeat expansion diseases have common epigenetic features such as
heterochromatin associated histone modifications, the presence of short/antisense RNA,
and hypermethylated CpG residue, and CTCF binding in the proximity of the repeats (AlMahdawi, Pinto, Ismail, Varshney, Lymperi, Sandi, Trabzuni and Pook, 2008; Cho,
Thienes, Mahoney, Analau, Filippova and Tapscott, 2005; Filippova, Thienes, Penn, Cho,
Hu, Moore, Klesert, Lobanenkov and Tapscott, 2001; Pietrobono, Tabolacci, Zalfa, Zito,
Terracciano, Moscato, Bagni, Oostra, Chiurazzi and Neri, 2005; Verdel, Jia, Gerber,
Sugiyama, Gygi, Grewal and Moazed, 2004). These similarities in epigenetic pathologies
on silenced alleles of each repeat expansion diseases suggest similar therapeutic
approaches to enhance the gene expression in an effort to alleviate disease symptom.
However, some of features are excluded when epigenetic pathology of each repeat
expansion disease defines, suggesting that distinct mechanisms responsible for repeatmediated chromatin remodeling in each repeat expansion disease may be present.
Therefore, my study that carefully define chromatin structures adopted by the
hyperexpanded GAA repeat will help not only understand shared epigenetic features in
repeat expansion diseases but also distinguish epigenetic features of FRDA from other
repeats expansion diseases.
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Chapter 6. Significance and Future Directions

Some parts of this dissertation were modified from the following journal article:
Eunah Kim, Marek Napierala, Sharon Y.R. Dent. Hyperexpansion of GAA repeats
affects post-initiation steps of FXN transcription in Friedreich’s ataxia, Nucleic Acids
Research, (2011) 39(19): 8366-8377.
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My studies define comprehensive distribution of histone modification at the FXN gene in
multiple lymphoid cell lines derived from FRDA patients and unaffected controls (Figure
28). I found that the hyperexpanded GAA repeats influence chromatin structure in the
regions flanking the GAA repeats, but these differences do not spread to the promoter.
On the contrary, the levels of RNA pol II and histone methylations representing
transcription elongation were significantly decreased at the FXN gene in FRDA cell lines.
These results strongly demonstrate that the transcription machinery is inhibited after
successful initiating FXN transcription in FRDA cells. Moreover, I first show that RNA
pol II is predominant at the FXN promoter-proximal region, appears to be paused, in
unaffected cell lines, but not FRDA cell lines. Comparison of altered H3K4me3 and
H3K79me2 levels at the FXN gene revealed that FXN deficiency is associated with
defective efficiency of transition from initiation to elongation of FXN transcription.
Taken together, my study provides strong indication that FXN insufficiency in FRDA
patients is caused by a defective transition at a post-initiation step of FXN transcription.
Perhaps heterochromatin-like structures in the vicinity of the hyperexpanded GAA
repeats act as an obstacle to produce full length FXN mRNA.

Regulatory elements located in the first intron affect expression of several genes (De
Jaco, Camp and Taylor, 2005; Lee, Dahi, Mahimkar, Tulloch, Alfonso-Jaume, Lovett and
Sarkar, 2005). Studies using deletion mapping of the FXN intron 1 revealed that the
intron 1 is capable of regulating FXN expression (Greene, Mahishi, Entezam, Kumari and
Usdin, 2007). Results of ChIP assay in this study demonstrate that the intronic region
upstream of the hyperexpanded GAA repeats exhibit the most significant differences of
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Figure 28. A summary of distributed histone modifications at the human FXN gene.
In FRDA cells, the FXN gene enriched with constellation of H3K9me3, H3K27me3, and
H4K20me3, strongly supporting that the FXN gene in FRDA cells has heterochromatinlike structures due to possibly the hyperexpanded tract of GAA repeats. This
phenomenon demonstrated in the GFP_GAA reporter system. H3K4me2, H3K36me3,
and H3K79me2 associated with euchromatin are decreased at the FXN gene in FRDA
cells as well as the GFP gene in the GFP_(GAATTC)

560

cells of the GFP_GAA

reporter system. Distribution of RNA pol II is repressed at the entire FXN gene in FRDA
cells compared to unaffected cells. RNA pol II seems to be poised at the downstream of
the transcription start site (TSS) of the FXN gene in unaffected cells, not FRDA cells.
Although the detailed mechanisms is unclear, heterochromatin-like structure at the
vicinity of the GAA repeats induced by the hyperexpanded GAA repeats lead to
consequence of FXN deficiency at the region downstream of the GAA repeats in FRDA
cells.
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Figure 28
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histone modifications between FRDA and control cell lines. The cytosine residue in this
region is preferentially methylated in FRDA patients (Greene, Mahishi, Entezam, Kumari
and Usdin, 2007). The levels of DNA methylation proportionally correlate with the
length of the GAA repeats (Castaldo, Pinelli, Monticelli, Acquaviva, Giacchetti, Filla,
Sacchetti, Keller, Avvedimento, Chiariotti and Cocozza, 2008). One of the methylated
cytosine is localized into an E-box motif (CANNTG). The c-Myc, a bHLH transcription
factor that recognize the E-box motif, interacts with the E-box resided in the region
upstream of the repeats in P493 cells (Fernandez, Frank, Wang, Schroeder, Liu, Greene,
Cocito and Amati, 2003). Moreover, the induction of c-Myc is associated with
enhancement of FXN transcription (Schuhmacher, Kohlhuber, Holzel, Kaiser, Burtscher,
Jarsch, Bornkamm, Laux, Polack, Weidle and Eick, 2001). Myc proteins allow the
paused RNA pol II to be released from promoter to activate gene expression (Rahl, Lin,
Seila, Flynn, McCuine, Burge, Sharp and Young, 2010). c-Myc physically interact with
components from chromatin modifying/remodeling complexes such as GCN5 to activate
gene expression

(Flinn, Wallberg, Hermann, Grant, Workman and Wright, 2002;

Kenneth, Ramsbottom, Gomez-Roman, Marshall, Cole and White, 2007). In the
unaffected cells, enrichments of H3K4me3, H3K4me2 and H3K79me2 in the region
upstream of the GAA repeats encompassing E-box motif potentially facilitate binding of
myc proteins in the E-box. Therefore, hypermethylated DNA sequences in the region
upstream of the GAA repeats in FRDA cells can influence the interactions between myc
proteins and the E-box motif (Guccione, Martinato, Finocchiaro, Luzi, Tizzoni, Dall'
Olio, Zardo, Nervi, Bernard and Amati, 2006; Perini, Diolaiti, Porro and Della Valle,
2005). My study here emphasizes the region upstream of the repeats is valuable as the
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regulatory element leading to appropriate FXN transcription. It is likely that epigenetic
changes in the intron 1 of the FXN gene induced by the hyperexpanded GAA repeats
interfere with transcriptional enhancers. Subsequently, reduced progression of
transcriptional machinery result in defective FXN expression in FRDA patients.
Additionally, c-Myc has been shown to interact with GCN5, an acetyltransferase
responsible for H3K9/14ac in eukaryotes (Flinn, Wallberg, Hermann, Grant, Workman
and Wright, 2002; Kenneth, Ramsbottom, Gomez-Roman, Marshall, Cole and White,
2007). The decreased levels of H3K9/14ac at the region upstream of the GAA repeats in
FRDA cells might result from failure of GCN5 recruitment at the region upstream of the
GAA repeats in FRDA cells. Reduced occupancy (or interaction) of C-Myc and GCN5 in
FRDA cells may lead to reduced recruitment of transcription machinery containing
RNAPII. This impaired recruitment may result in particular constellation of histone
methylations marking repressive chromatin structures at FXN gene in FRDA patients as I
observed. In order to investigate this possibility, distribution of c-Myc and GCN5 could
be defined by ChIP-seq in the lymphoid cell lines. Unfortunately, there are no appropriate
antibodies for GCN5 and c-Myc ChIP. Alternatively, distribution of histone modification
at the FXN gen can be determined in either the absence or over expression of either cMyc or GCN5 in lymphoid cell lines. However, the lymphoid cell lines exhibit
technically low efficiency of transfection. It would take longer time to set a condition to
optimize transfection activity. Alternatively, other cell lines such as K562 and HEK293T
cells as general cell lines can be utilized to investigate effect of c-Myc or GCN5 in FXN
transcription. However, this system will exclude effect of the hyperexpanded GAA
repeats to understand the roles of c-Myc or GCN5 in FXN transcription. The GFP_GAA
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system will be a suitable system. However, this system also has limitations that the
artificial condition in the GFP_GAA system may not be correlated with actual cellular
function to the heterochromatin-like structure at the FXN gene in FRDA patients.
Moreover, since several studies suggest that intronic region of the FXN gene have
regulatory function in FXN transcription, the GFP_GAA system has weakness that have
non-FXN intronic sequence to regulate either GFP transcription and chromatin structure
change.

During transcription consisting of series of phase such as initiation, elongation, and
termination of RNA transcript by RNA pol II, the promoter-proximal pausing of RNAPII
is a rate-limiting step to produce full-length transcription(Guenther, Levine, Boyer,
Jaenisch and Young, 2007). I found that levels of RNA pol II is impaired at the promoterproximal region of the FXN gene in FRDA cells. More interestingly, the SAGA complex
that contains GCN5 and the Mediator complex have important roles in inducing
appropriate levels of gene expression from poised promoters in budding yeast (Lee,
Fletcher, Zhang, Chen, Fischbeck and Stargell, 2010). Moreover, c-Myc is involved in
the release of paused RNA pol II from the promoter-proximal region of a given gene
(Rahl, Lin, Seila, Flynn, McCuine, Burge, Sharp and Young, 2010). These results raise
the possibilities that c-Myc bound to the E-box in the region upstream of the GAA
repeats might be involved in release of paused RNA pol II at the promoter-proximal
region of the FXN gene.

To further confirm that paused RNA pol II regulates FXN expression, I would examine
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additional transcription factors, DRB sensitivity-inducing factor (DSIF) and negative
elongation factor (NELF) as well as P-TEFb using conventional ChIP technique. DSIF
and NELF are sufficient to stall RNA pol II at the promoter-proximal region of genes
(Wu, Yamaguchi, Benjamin, Horvat-Gordon, Washinsky, Enerly, Larsson, Lambertsson,
Handa and Gilmour, 2003). The paused RNA pol II is released from the promoterproximal region by phosphorylation of NELF by P-TEFb (Rahl, Lin, Seila, Flynn,
McCuine, Burge, Sharp and Young, 2010). The P-TEFb is necessary to release the
paused RNA pol II by phosphorylation of NELF (Peterlin and Price, 2006). Inhibition of
P-TEFb induces accumulated RNA pol II at the most of genes, suggesting that majority
of gene is regulated by pausing of RNA pol II (Cheng and Price, 2007; Peterlin and Price,
2006). C-myc is associated with activation of P-TEFb to release paused RNA pol II
(Rahl, Lin, Seila, Flynn, McCuine, Burge, Sharp and Young, 2010). Successful release of
the paused RNA pol II from the promoter-proximal region of genes is necessary to
elongate full-length transcripts (Saunders, Core and Lis, 2006). Artificial recruitment of
P-TEFb at the Hsp70 gene under uninduced conditions increases basal Hsp70 expression
(Lis, Mason, Peng, Price and Werner, 2000). This result suggests that the FXN gene in
FRDA may have less P-TEFb compared to unaffected controls. To investigate this
possibility, I could first treat pharmacological inhibitor of P-TEFb in lymphoid cell lines
followed by ChIP for total RNA pol II at the FXN gene.

Phosphorylation at serine 2 in the CTD of RNA pol II by P-TEFb is indicator of ongoing
elongation of full-length transcripts (Peterlin and Price, 2006). Unfortunately, I couldn’t
detect appreciative levels of phosphorylated serine 2 of RNA pol II by conventional
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ChIP. Instead, nuclear run on assay is possibly able to detect elongating full-length FXN
transcripts. If paused RNA pol II is associated with regulation of FXN transcription, I
would detect increased phosphorylated RNA pol II at serine 2 upon the treatment of
pharmacological P-TEFb inhibitor in FRDA cells.

Levels of H3K9me3 have been less correlated with FXN transcription, suggesting that
levels of H3K9me3 are not the primary means to induce the heterochromatin-like
structure facilitated by the GAA repeats. This suggestion allows me to hypothesize that
hyper DNA methylation at the region upstream of the GAA repeats in FRDA cells is
associated with altered histone modifications as is observed in my studies. Although the
relationship between DNA methylation and histone modifications has not been fully
understood, these two systems may play a part in regulating repressive chromatin
structures. To investigate the effect of the DNA methylation in FXN transcription as well
as altered chromatin structure at the FXN gene in FRDA cells, I would examine
distribution of more histone modifications and total RNA pol II after removal of DNA
methylation using 5-aza-2-deoxycytidine, an inhibitor of DNA methylation. If there is no
change in histone modifications, it would further demonstrate that hyper DNA
methylation in FRDA patients is involved in a different mechanism to silence FXN
transcription in FRDA patients. If there are changes in histone modifications associated
with the transcription process after 5-aza-2-deoxycytidine treatments, I will be able to
determine which step of FXN transcription is affected by high levels of the DNA
methylation at the region upstream of the GAA repeats in FRDA patients. To further
demonstrate that the observations after removal of DNA methylation result from the
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hyperexpanded GAA repeats per se, not either inherent characteristics of the FXN gene, I
will take advantage of the GFP_GAA system. First of all, I will examine the levels of
DNA methylation at the region upstream of the GAA repeats in the GFP_GAA cell lines
to see the expanded GAA repeats induce DNA methylation in the vicinity of the repeats
using either MS-PCR or bisulphate sequencing. If there are no DNA methylation changes
in the GFP_GAA cells, one possibility is that the GAA repeats do not induce DNA
methylations. The histone modification changes by the GAA repeats are primary factors
to restore FXN transcription in FRDA. Another possibility is that 560 GAA repeats
insufficient to induce DNA methylation to silence gene expression since the DNA
methylation is correlated with the length of the GAA repeats in FRDA patients. If the
GFP_(GAATTC) 560 cells have more DNA methylation compared to the
GFP_(GAATTC) 0 cells, I should determine which factor between DNA methylation
and histone modification can be more important/first targets to restore FXN transcription
by additional experiments.

Although we detected no antisense FXN transcripts at the FXN locus, we cannot exclude
possibility that there are double strand RNAs originating from the hyperexpanded GAA
repeats to form RNAi-mediated heterochromatin-like structures at the FXN gene in
FRDA cells. Moreover, the presence of H3K9me3 overlaps with RNAi-mediated
heterochromatin formation in fission yeast (Cam, Sugiyama, Chen, Chen, FitzGerald and
Grewal, 2005). Although I observed significant levels of H3K9me3 at the region
upstream of the GAA repeat in FRDA cells, I could not detect any isoforms of HP1
protein. This suggest different pathway to form heterochromatin-like structure at the FXN
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gene. The argonaute protein is a key player to participate in RNAi-mediated gene
silencing as part of the RNA-Induced Transcriptional Silencing (RITS) complex
mediating RNAi pathway to heterochromatin assembly (Buker, Iida, Buhler, Villen,
Gygi, Nakayama and Moazed, 2007). The identifying small RNAs and proteins
associated with the RITS complex at the FXN gene in FRDA will determine if the
hyperexpanded GAA repeat is involved in RNAi-mediated FXN silencing via assembly
of heterochromatin in FRDA.

Although expansion of the GAA repeats is the primary factor driving chromatin changes,
the possibilities that metabolic changes resulting from frataxin deficiency in FRDA cells
contribute to shaping of epigenetic landscape at the FXN gene has not been excluded.
Frataxin is associated with protestation of cells against cytotoxic stress that might be
involved in the fine-tuning regulation of FXN expression (Jiralerspong, Ge, Hudson and
Pandolfo, 2001).

Moreover, HDACi treatments have no association of H3K9me3 levels at the FXN gene in
FRDA cells in despite of enhancing FXN expression (Herman, Jenssen, Burnett, Soragni,
Perlman and Gottesfeld, 2006; Punga and Buhler, 2010). This result suggests that
inhibition of acetylation on non-histone is involved in the regulation of FXN transcription
as well as chromatin structure changes at the FXN gene in FRDA cells. Therefore, global
analyses of nucleosome position and histone modifications in FRDA are necessary to
reveal the full spectrum of epigenetic consequences of reduced frataxin levels.
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Overall, my study will help to clarify underlying mechanisms of how epigenetic changes
observed in the vicinity of the hyperexpanded GAA repeats at the FXN gene are
associated with FXN deficiency in FRDA patients. Furthermore, this study can
potentially be developed to investigate therapeutic targets (e.g. methyltransferase or
demethylase responsible for altered histone modifications observed in my studies) for
curing FRDA.
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Figure 29. A working model of heterochromatin-like structure formation at the
FXN gene in FRDA.
HDACs are recruited to the FXN gene and remove acetyl group at the N-terminal tail of
the histones. Histone lysine methyltransferase add methyl group at the N-terminal tail of
the histones in the vicinity of the hyperexpanded GAA repeats in FRDA cells. According
to the distribution of RNA pol II in the lymphoid cell lines, the fate of RNA pol II is first
likely to be determined at the promoter-proximal region (+48 bp) to regulate either FXN
expression or chromatin structures. At the region upstream of the GAA repeats, RNA pol
II would be inhibited to elongate FXN transcription through one of mechanisms in
following, which lead to FXN deficiency in FRDA patients. One is that either non-B
DNA structure or heterochromatin-like structure induced by the hyperexpanded tract of
GAA repeats inhibit recruitment of chromatin modifying/remodeling complexes or DNA
methyltransferase. Another is that methylated CpG residue at the E-box (CACGTG) in
FRDA inhibits binding of transcription factors such as c-Myc, which lead to low levels of
RNA pol II and altered histone modifications resulting in FXN deficiency in FRDA.
Moreover, antisense FXN transcripts from the hyperexpanded GAA repeats in FRDA
patients can be involved in small RNA-mediated heterochromatin formation.
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Figure 29
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